





Title of dissertation: ACTIVITY-DEPENDENT REGULATION OF 
SCHWANN CELL DEVELOPMENT BY 
EXTRACELLULAR ATP 
 
    Beth Stevens, Doctor of Philosophy, 2003 
 
Dissertation directed by: Professor Roger W. Davenport 
    Department of Biology 
    Dr. R. Douglas Fields 
    NICHD, National Institutes of Health 
 
 
 During development, the importance of activity-dependent plasticity in 
neurons is widely appreciated, but comparatively less is known of the role of 
electrical activity in controlling glial development.  Schwann cells (SCs)--the 
myelinating cells in the peripheral nervous system--are critically dependent on 
axons during the perinatal period, but axonal signals controlling SC development 
and myelination have remained elusive. The onset of high frequency action 
potential activity along developing peripheral nerves corresponds to the period 
when SCs are exiting the cell cycle and initiating myelination.  We postulated that 
neural impulse activity could play an instructive role in regulating SC gene 
expression and function during development.  
 To address these questions, a neuron/SC co-culture system equipped with 
stimulating electrodes was used to evoke action potentials in dorsal root ganglion 
neurons (DRGs), and study the ensuing effects in pre-myelinating SCs.  We found 
that SCs can detect neural impulse activity in pre-myelinated axons, and the 
activity-dependent axon-Schwann cell signaling molecule was identified as 
extracellular ATP.  Activity-dependent release of ATP activated multiple 
intracellular signaling pathways in SCs, and increased levels of several 
transcription factors, including CREB, c-fos, and krox-24.  Importantly, we found 
that ATP has profound effects on SC development. Activity-dependent ATP release 
significantly inhibited SC proliferation, arrested SC differentiation, and completely 
prevented the formation of myelin. 
 Extracellular ATP can activate multiple types of purinergic receptors; 
therefore we explored the specific purinergic receptors and signaling pathways that 
could mediate this form of activity-dependent neuron-SC communication.  Using a 
combination of pharmacological and molecular approaches, we found that pre-
myelinating SCs express a far more complex array of ATP receptors (P2X and 
P2Y) that previously thought.  Surprisingly, we discovered that pre-myelinating 
SCs also express a class of functional adenosine receptors (A2), which are 
positively coupled to cAMP.  Extracellular adenosine, a breakdown product of 
ATP, regulated MAP Kinase signaling and proliferation in SCs independently of 
ATP.  Collectively, our findings suggest that ATP and adenosine released from 
electrically active axons activate a complex intracellular signaling network in SCs, 
in which ATP and adenosine act together to regulate SC function during 
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 Myelination is one of the most complex cell-cell interactions that exist 
in biology.  The process requires recognition, association, ensheathment, and 
elaboration of glial membrane around the appropriate axon at precisely the 
right time in development.  The end result is the formation the compact 
myelin sheath, which is essential for rapid propagation of nerve impulses 
along central and peripheral vertebrate axons.  The significance of myelin can 
not be disputed.  Its importance in nervous system function is especially 
highlighted in demyelinating diseases or pathologic conditions in which 
myelin has broken down.    
 Myelination is achieved by two glial cell types --oligodendrocytes in 
the central nervous system (CNS) and Schwann cells in the periphery (Figure 
1).  Schwann cells myelinate a single axon segment, where as 
oligodendrocytes can myelinate several.  We have come far in our 
understanding of the cellular and molecular architecture of myelin, but 
incredibly, the extracellular signals that initiate the myelination program 
remain a mystery.  It is well established that myelinating glia are dependent 
on continual communication with axons during embryonic and early postnatal 
development. The prevailing view is that myelination is controlled by the 







properties determine whether it will become myelinated.  A second is that 
myelination is induced by contact-dependent and/or soluble axonal  
signals.  There is evidence to support both sides, and while this topic is highly 
contentious, there is general agreement that axonal signals are necessary, 
especially in the peripheral nervous system (PNS). 
  Myelination enables rapid propagation of neural impulses along 
developing axons, but could impulse activity regulate myelination?  Evidence 
from several model systems have established a fundamental role for electrical 
activity in modifying developing neural circuits (Katz and Shatz, 1996; Zhang 
and Poo, 2001).  Glial cells are intimately associated with developing neurons 
at synapses and along fiber tracts, yet the role of neural activity in controlling 
glial development has not been adequately explored.  The onset of neural 
impulse activity along developing axons corresponds to the period when 
myelinating glia are undergoing dramatic changes in gene expression, 
proliferation, differentiation into myelin forming cells (Fitzgerald, 1987; 
Mirsky and Jessen, 1999).   Could impulse activity also provide instructive 
signals to developing glia? 
 There is growing evidence that activity-dependent neuron-glia 
communication occurs in the mature nervous system. With the development 
of new techniques and tools with which to study glia, it is becoming 
increasingly clear that glial cells can actively communicate with neurons.  







express many of the same ion channels, and receptors systems as neurons, and 
thus are well equipped to receive and transmit neuroactive signals (Fields and 
Stevens-Graham, 2002).  Indeed, activity-dependent calcium transients have 
been observed in glia at the synapse (Castonguay et al., 2001; Haydon, 2001), 
and along mature myelinated axons (Lev-Ram and Ellisman, 1995), but 
activity-dependent neuron-glia communication along developing axons has 
not been previously demonstrated.   
 The rodent sciatic nerve is an accessible mammalian model in which to 
study the effects of neural impulse activity on glial development and 
myelination in vivo, and in vitro.   In contrast to oligodendrocytes, SCs are 
strictly dependent on axonal signals for induction of myelin gene expression 
and initiation of myelin.  Each stage of Schwann cell development has been 
extensively characterized, both at the morphological and molecular levels, 
making the sciatic nerve an excellent model system for studying the signals 
that regulate SC development (Mirsky and Jessen, 1996, 1999).  In addition, 
in vivo electrophysiological recordings in rodent sensory neurons have 
established that the onset of spontaneous and low frequency neural impulse 
activity corresponds to a critical period of SC development before the onset of 
myelination (around birth), when action potential activity could provide 
instructive signals to SCs (Fitzgerald, 1987).   A major goal of this research is 
to determine whether developing SCs respond to neuronal activity, and to 







the cellular and molecular mechanisms controlling Schwann cell development 
could lend important insight into these questions.    
 
SCHWANN CELL DEVELOPMENT: AN OVERVIEW 
  Schwann cells are critically dependent on axonal signals throughout 
embryonic and postnatal development.  SC precursor cells originating from the 
neural crest migrate along developing peripheral axons and undergo a series of 
well-defined, morphologically distinct developmental stages characterized by 
specific patterns of gene expression (Jessen and Mirsky, 2002)(see fig. 2).  
There are 3 major transitions: generation of SC precursors from migrating 
neural crest cells ( ~E 14 in rat ), transition from SC precursor to 
embryonic/pre-myelinating SCs ( ~E16-birth), and finally the divergence of 
the SC lineage into mature myelinating or non-myelinating phenotypes from 
birth through the first 2-3 postnatal weeks (Jessen and Mirsky, 1999a; Mirsky 
and Jessen, 1999).  These two cell types exist in approximately equal numbers 
in adult peripheral nerves.  Myelinating Schwann cells wrap multiple layers of 
cell membrane around a single axon, whereas non-myelinating SCs ensheath 
multiple small diameter axons.  In addition to morphological and functional 
differences, a set of molecular markers distinguish the two phenotypes (see fig. 
2).  Despite major progress in understanding the cellular and molecular 







Figure 1.   Major categories of glia in the nervous system. 
 (a) Non-myelinating Schwann cells, labeled by fluorescence 
immunocytochemistry for the S-100 protein, appear spindle shaped when 
cultured without axons (left).  Myelinating Schwann cells undergo dramatic 
changes in morphology, extending multiple wraps of myelin membrane around 
a single axonal segment. Myelinated segments are interrupted by regularly 
spaced Nodes of Ranvier, which serve to propagate action potentials over great 
distances. (b) A cultured oligodendrocyte, immunostained with myelin-basic 
protein (MBP) displays several elaborate extensions of myelin membrane. In 
contrast to Schwann cells, a single oligodendrocyte can myelinate multiple 
axons (right).  (c) Astrocytes do not form myelin, but they communicate with 
neurons, glia, and blood vessels to regulate diverse functions in the CNS. 
Cultured rodent astrocytes, stained with the astrocytic marker GFAP are 

















Figure 2.  Correlation between Schwann cell development and changes in 
neural impulse activity in rat sensory neurons during the perinatal period. 
A. An outline of Schwann cell development based on the rat sciatic nerve.  
PreM-SC, pre-myelinating Schwann cell. ProM-SC, promyelinating Schwann 
cell. M-SC, myelinating Schwann cell. N-M SC, non-myelinating Schwann 
cell.  This diagram summarized the profile of markers used to define distinct 
developmental stages in both the myelinating and non-myelinating Schwann 
cell lineages.   
B. The rate of Schwann cell proliferation increases in late fetal development 
and begins to decrease near the time of birth, just prior to the onset of 
myelination. 
C.  Action potentials from rat DRG neurons show the onset of active 






















that direct a Schwann cell toward the myelinating or non-myelinating fate has 
not been identified.   
 Schwann cells are exceptionally plastic cells.  While the specific axon 
signal (s) that regulate each key stage of SC development are not known, a 
number of important growth factors and soluble signals have been described 
(Stewart et al., 1991; Zorick and Lemke, 1996; Jessen and Mirsky, 2002).  
Interestingly, the biological consequences of an extracellular signal appear 
largely dependent on the developmental period, and/or the environmental 
context.  This is exemplified by the neuregulin family of growth factors 
(otherwise known as glial growth factor (GGF), heregulin/ARIA, neu 
differentiation factor), which have profound effects on SC development at 
multiple stages (Topilko et al., 1996; Jessen and Mirsky, 1997; Garratt et al., 
2000; Jessen and Mirsky, 2002).  Very early in SC development (i.e. E14), β-
neureg-1/erbB3 receptors are essential for the generation SC precursors from 
neural crest cells.  Neuregulins promote the survival and migration of SC 
precursor cells (Mirsky and Jessen, 1999), and have also been shown to play 
and instructive role early in SC development (Shah et al., 1996). The transition 
from precursor to pre-myelinating SCs is also dependent neuregulin (Dong et 
al., 1995).  During the pre-myelinating stage (~E16), SCs initiate autocrine 
survival loops, and become independent of neuregulin for survival.  However, 







vitro (Dong et al., 1995; Kim et al., 1997a).  In addition, neuregulins can 
induce the expression of myelin-related transcription factors (Murphy et al., 
1996; Wu et al., 2001).  At later stages, neuregulin can dramatically inhibit SC 
alignment, ensheathment, and myelination (Zanazzi et al., 2001). In fact, 
treatment of mature, myelinated SC cultures with neuregulin can induce 
striking de-myelination (Zanazzi et al., 2001) . Together, these findings 
suggest that the same extracellular signal can have diverse functional effects in 
SCs depending upon the biological context.   
 Schwann cell plasticity is further demonstrated following peripheral 
nerve injury or pathology.  Unlike oligodendrocytes, Schwann cells are 
capable of de-differentiating following denervation. This has been 
demonstrated in vivo  following axotomy, as well as in cell culture models 
(Scherer, 1997; Jessen and Mirsky, 1999b).  It is this remarkable plasticity that 
likely contributes to Schwann cells unique ability to promote regeneration and 
re-myelination in the PNS.  Following axon degeneration, the myelin sheath 
breaks down and myelinating SCs down-regulate expression of myelin-related 
proteins and mRNAs.  SCs de-differentiate into a phenotypes resembling pre-
myelinating SCs, after which many developmental events including 
proliferation, differentiation and myelination are recapitulated. Thus, 
understanding the signals that regulate pre-myelinating SCs during 
development could also lend insight into the mechanisms that control 








REGULATION OF SCHWANN CELL PROLIFERATION  
 SCs continue dividing after migration into peripheral nerves, and SC 
proliferation ceases around the time of birth.  It is well established that SC 
proliferation is regulated by contact with axons, and axon-derived factors.   
Direct contact of SCs with the axolemma, sustains SC proliferation until 
initiation of axon ensheathment (Salzer et al., 1980; DeVries et al., 1982; 
Ratner et al., 1985).  In vivo studies in the rat sciatic nerve demonstrated a rise 
in SC proliferation between E17-19, followed by a dramatic decline ~ 2 days 
before the onset of myelination (Stewart et al., 1993).  Among the most 
convincing candidates for axonal mitogens is neuregulin (Morrissey et al., 
1995; Maurel and Salzer, 2000). The mitogenic effects of β -neuregulin on glia 
have been observed in several species including humans (Kim et al., 1997; 
Levi et al., 1995; Morrissey et al., 1995; Rutkowski et al. 1995). In addition, 
axon-induced mitogenic responses can be inhibited with antibodies to 
neuregulin and to neuregulin receptors erbB2 in DRG/SC co-cultures 
(Morrissey et al.).  In vitro models have identified a  number of signals that 
promote SC proliferation, either alone or in concert with signals that elevate 
intracellular cAMP levels including bFGF, PDGF, IGF, TGF-β, endothelins 
(Davis and Stroobant, 1990; Eccleston et al., 1990; Schumacher et al., 1993; 








 While significant progress has been made in identifying factors that 
stimulate Schwann cells to divide, much less is known about the extracellular 
signals that negatively regulate SC mitosis in vivo, and in vitro. Just before 
birth, pre-myelinating SCs undergo a dramatic decline in their proliferation 
rate, which is a pre-requisite for induction of SC differentiation and 
myelination (Asbury, 1967; Stewart et al., 1993).  Several tissue culture studies 
have established that only post-mitotic SCs are responsive to myelin-inducing 
axon signals.  Other factor (s) likely over-ride pro-mitotic axonal signals to 
suppress the growth cycle in SCs, but the identity of these anti-proliferative 
signals in developing peripheral nerves is unknown.  Thus, mechanisms that 
arrest SC proliferation could indirectly regulate myelination by enabling SCs 
to respond to myelin-inducing signals at the appropriate time.  A major aim of 
this research will be to determine whether action potential activity can 
influence SC proliferation at the pre-myelinated stage. 
 
SCHWANN CELL DIFFERENTIATION AND MYELINATION 
 Myelination involves a highly regulated sequence of molecular 
interactions between axons and Schwann cells.  Significant progress has been 
made in identifying key intracellular signals and genes involved in myelination 
in the PNS.  There is compelling evidence in vitro and in vivo that continual 
axon-SC signaling is essential for the formation and maintenance of the myelin 







 Cyclic AMP (Hutchinson et al.) has been implicated as an important 
second messenger, and is thought to mimic axon signals in vitro (Morgan et 
al., 1991). Agents that increase intracellular cAMP levels in non-dividing SCs 
dramatically up-regulate myelin gene expression, and induce morphological 
changes associated with the myelinating phenotype.  In culture, exposure of 
SCs to forskolin or differentiating media induce the transition of bipolar, 
spindle-shaped Schwann cells to rounded flattened cells that intimately 
associated with axons (Sobue et al., 1986).  Myelinating Schwann cells 
sequentially up-regulate a series of myelin genes involved in the formation and 
maintenance of the myelin sheath (P0, PMP22, MBP), and down-regulate 
several of the markers expressed by immature and mature non-myelinating 
Schwann cells (Zorick and Lemke, 1996; Scherer, 1997; Mirsky and Jessen, 
1999)(see fig 2).  
  Several transcription factors have also been shown to be differentially 
regulated in myelinating and non myelinating SCs.   As shown in figure 2, 
Krox 24, c-jun and Pax 3 are expressed by non-myelinating and denervated  
SCs, while Krox 20, and SCIP (Oct6/tst-1) are expressed in  myelinating SCs 
(Scherer, 1997).  The zinc family transcription factor, Krox-20 is essential  for  
PNS myelination (Topilko et al., 1994; Murphy et al., 1996; Zorick et al., 
1996).  Studies carried out in vivo have revealed Krox-20 is expressed in 
embryonic SCs before the onset of myelination, but its expression is later 







transcription factor SCIP, is expressed transiently in the pro-myelinating stage 
of both phenotypes, and appears to play a role in determining the timing of cell 
cycle withdrawal and induction of myelination.  Recent work by Zorick et al. 
(1996) demonstrated that SCIP is significantly up-regulated in krox-20 
mutants, suggesting a link between these two transcription factors.  In contrast 
to Krox-20,  Krox-24 expression is generally restricted to the non-myelinating, 
denervated, proliferating Schwann cells (Topilko et al., 1997).  Interestingly, 
there is a narrow window at birth when the two genes are co-expressed in 
Schwann cells, and it has been suggested that krox-24 may suppress the 
expression of myelin-related genes, or enhance the expression of non-
myelinating genes during development and regeneration (Topilko et al., 1997).   
  Inhibition of SC proliferation and the subsequent induction of 
differentiation and myelin gene expression occur within a narrow window 
before birth.  Identifying candidate axonal signal(s) that are present during this 
critical period in SC development may contribute a better understanding of 
how SC proliferation and myelination is regulated. Spontaneous and stimulus- 
evoked neural activity begins along developing sensory axons during this time, 
and as we shall see below, there is functional evidence that electrical activity 









ACTIVITY-DEPENDENT REGULATION OF GLIAL DEVELOPMENT 
 Activity-dependent axon-glial communication has been proposed to 
influence glial proliferation in the developing optic nerve.  Barres and Raff 
reported that proliferation of oligodendrocyte precursor cells (OPCs) depends 
on electrical stimulation in neighboring axons (Barres and Raff, 1993) .  
Intraocular injection of TTX in developing rat optic nerve significantly 
reduced OPC proliferation, and this TTX-dependent inhibition of proliferation 
was rescued with the growth factor, PDGF, indicating that electrical activity 
could stimulate the production and release of mitogens that stimulate OPC 
proliferation. The authors suggested that electrically active axons produce a 
signal that stimulates type 1-astrocytes to release PDGF, since astrocytes are a 
major source of PDGF in developing optic nerve.  However, this hypothesis 
was not further explored, and the axonal signal(s) were not identified.  In the 
same year, Kreigler and Chiu observed calcium transients in developing optic 
nerve glia in response to axonal firing, but neither the type of glial cell nor the 
activity-dependent signal were identified (Kriegler and Chiu, 1993).  
 Several lines of evidence from the central and peripheral nervous 
systems suggest that the onset of neural impulse activity can affect initiation of 
myelination.    Earlier studies in the optic nerve demonstrated that mice reared 
in the dark developed fewer myelinated axons compared with control mice 







the naturally blind cape-mole rat (Omlin, 1997), whereas myelination was 
accelerated by premature eye opening in rabbit optic nerves (Tauber et al., 
1980).  More recent experiments in CNS neurons revealed that electrical 
activity can promote myelination.  Blockade of sodium-dependent action 
potentials with tetrodotoxin (TTX) significantly inhibited myelination in vitro, 
and in developing optic nerve in vivo, while increasing neuronal firing with α-
scorpion toxin enhanced myelination (Demerens et al., 1996).  The molecular 
mechanisms underlying these activity-dependent effects on myelination are not 
known.  A number of molecules were proposed, including cell adhesion 
molecules, extracellular potassium, and the release of a soluble axonal signal 
(Demerens et al., 1996; Zalc and Fields, 2000).  
 Opposite effects of neural impulse activity on myelination have been 
reported in the PNS.  Recent experiments from our laboratory have shown that 
electrical activity can inhibit myelination the PNS by changing membrane 
properties of developing axons (Stevens et al., 1998). Homophilic interactions 
between L1 on axons and Schwann cells are important for ensheathment and 
the initial stages of myelination (Seilhemer and Schachner 1988; Wood et al., 
1990).   We found that myelination of dorsal root ganglion (DRG) axons by 
Schwann cells was inhibited following electrical stimulation of axons at a low 
frequency (0.1 Hz) via down-regulating mRNA and protein levels of the cell 







 Given the expanding evidence that glial cells can actively respond to 
neuronal activity, it is plausible that action potential activity along developing 
axons could also influence SC myelination through the release of activity-
dependent soluble signals. A closer look into the mechanisms underlying 
activity-dependent neuron-glia communication in the adult nervous system 
could provide insight into candidate activity-dependent signals regulating 
axon-Schwann cell communication during development. 
 
GLIAL CELLS ARE EXCITABLE 
 The notion that glial cells are active, excitable cells emerged with the 
advent of new techniques with which to study neuron-glia communication.  
Glial calcium signaling is a measurable indicator of glial excitability, 
providing a powerful tool to study glial cells in action. Time-lapse calcium 
imaging in several model systems have recently demonstrated that glia located 
at synapses respond to neuronal activity with increases in intracellular calcium 
(Araque et al., 1999; Castonguay et al., 2001; Haydon, 2001).  Likewise, 
chemical or mechanical stimulation of astocytes can elicit calcium responses 
in nearby neurons.  Astrocytes can also actively communicate with one 
another.  Stimulation of one astrocyte, can trigger a local elevation in 
astrocytic calcium that can subsequently spread to neighboring astrocytes in 
the form of a calcium wave, which can propagate at a rate of 100 µm/sec.  







of second messengers through gap junctions, and extensive chemical signaling 
along astrocytic networks. 
 Several important mechanisms underlie the excitability of glial cells.  
First, glial cells express most types of voltage-gated ion channels (Barres et 
al., 1990; Deitmer et al., 1998; Verkhratsky and Steinhauser, 2000). 
Potassium channels are by far the most prevalent, which is consistent with the 
critical role of glia in buffering extracellular K+ during neural activity.  Glial 
cells also express several types of calcium channels (predominantly L and T 
types), in addition to chloride channels. Ca2+ channels have been 
demonstrated in astrocytes in vivo and in situ (MacVicar et al. 1991; Duffy 
and McVicar 1994), as well as in perisynaptic Schwann cells at the 
neuromuscular junction (Robitaille et al., 1996).  Although glia lack the 
membrane properties to generate action potentials, voltage –gated Na+ 
channels have been found in astocytes (Barres et al., 1989; Steinhausser et al, 
1994; Schaller et al. 1995), and in Schwann cells (Chiu, 1991).   Na+ channels 
are thought to be involved in the regulation Na+ homeostasis and Na+ –
dependent transporters. 
 Glial cells also express functional receptors for most neurotransmitters, 
including ionotropic (non-NMDA) and metabotropic glutamate receptors, in 
addition to GABAergic, adrenergic, cholinergic, purinergic, and serotonergic 
receptors.  Glial cells also express receptors for several neuropeptides, 







Shao and McCarthy, 1995; Vernadakis, 1996; Verkhratsky and Steinhauser, 
2000).  Finally, activity-dependent activation of glial receptors can induce the 
calcium-dependent synthesis and release of several neuroactive substances, 
including glutamate, ATP, and prostaglandins (Parpura et al., 1995; 
Castonguay et al., 2001).  For example, cultured Schwann cells have been 
shown to release glutamate in response to extracellular ATP (Jeftinija and 
Jeftinija 1998).  Through these mechanisms, activity-dependent release of 
neuroactive substances from glia could have broad implications in modulating 
both neurons and glia at the synapse and in extrasynaptic regions of axons.   
 
 
ACTIVITY-DEPENDENT NEURON-SCHWANN CELL 
COMMUNICATION  
 Emerging evidence in the adult nervous system indicate the Schwann 
cells respond to neuronal activity.   Activity-dependent axon-SC signaling has 
been observed in situ in the paranodal region of peripheral nerves during 
axonal activity (Lev-Ram and Ellisman, 1995).  Axonal stimulation (5 min 20 
Hz stimulation) induced calcium transients in myelinating SCs at the Node of 
Ranvier, presumably as a result of accumulation of extracellular potassium at 
the node (Lev-Ram and Ellisman, 1995).   
 Activity-dependent axon-SC communication has been most extensively 







studies performed at the in-tact frog and mouse NMJ have demonstrated that 
terminal Schwann cells surrounding neuromuscular junctions in the PNS, 
respond to synaptic release of neurotransmitters, such as glutamate and 
acetylcholine, with increases in intracellular calcium.  These activity-
dependent calcium fluxes can regulate glial intracellular signaling pathways, 
and gene expression.  For example, tetanic stimulation of the presynaptic 
motor nerve axon was shown to elicit calcium transients in terminal Schwann 
cells, which down-regulated expression of GFAP via activation of 
acetylcholine (ACh) receptors on SCs (Georgiou et al., 1999).  
 Extracellular ATP can also mediate activity-dependent signaling 
between neurons and terminal Schwann cells.   ATP is co-released with 
neurotransmitters at synapses in an activity-dependent manner, and terminal 
Schwann cells express several types of purinergic receptors.  It was recently 
demonstrated that blockade of ATP receptors in SCs reduced the size and onset 
of activity-dependent Ca2+ transients in terminal SCs, suggesting that 
purinergic receptors on perisynaptic SC’s are activated by ATP released by 
synaptic transmission (Robitaille, 1995). 
 Extrasynaptic release of ATP along axons has not been previously 
demonstrated, but activity-dependent non-synaptic release of adenosine has 
been shown in studies if the rabbit vagus nerve (Maire et al., 1984).    There is 
evidence for non-synaptic release ATP from various cell types.  In fact, ATP 







waves (Cotrina et al., 1998; Guthrie et al., 1999).  Extracellular ATP released 
from stimulated astrocytes activates metabotropic purinergic receptors on 
neighboring cells (Fam et al., 2000).  Together these findings suggest that 
extracellular ATP could serve as an activity-dependent signal between axons 
and developing Schwann cells.   
 
PURINERGIC RECEPTORS IN GLIAL CELLS  
 Recent evidence indicate that all glial cell types express membrane 
receptors for extracellular ATP (Fields and Stevens, 2000).  ATP has several 
unique characteristics that make it a potent neuron-glia transmitter; it is highly 
diffusible in the extracellular space, it rapidly degrades into adenosine by ecto-
nucleotidases, and it can activate a complex set of purinergic receptors which 
could have diverse biological outcomes depending on the cell type and 
environmental context. 
 Extracellular purines (ATP, adenosine, and ADP) and pyrimidines 
(UTP, and UDP) are important signaling molecules that mediate diverse 
biological function inside and outside of the nervous system (Ralevic and 
Burnstock 1998).  Membrane receptors for extracellular purines are a complex 
class of receptors that can be grouped into two main families; the P2 receptors 
for ATP, and the P1 receptors for adenosine.  The ATP (P2) receptor family 
can be subdivided into ionotropic (P2X) and metabotropic (P2Y) receptors, 







receptors (P2X 1-7) and eight P2Y (P2Y1, 2, 4, 6, 11, 12, 13, 14) have been cloned and 
characterized (Ralevic and Burnstock, 1998) (see fig. 3).     
  Adenosine (P1) receptors have been characterized into four subtypes: 
A1, A2A and A2B and A3, all of which couple to G proteins.  A1 and A3 
adenosine receptors act through intracellular calcium and inhibit adenylate 
cyclase, where as the A2 class of receptors are positively coupled to cAMP 
(Fields and Stevens, 2000; Klotz, 2000). As shown in Fig 3, selective agonists 
and antagonists have been developed for many of P1 and P2 receptors, 
allowing pharmacological characterization of purinergic expression and 
function. The list of selective compounds continues to expand, and serve as 
useful tools for studying purinergic receptor function in vivo and in vitro.  A 
combination of molecular, pharmacological, and functional approaches should 
be used to characterize a specific subtype, since the dose and selectivity of 
many of these compounds varies with species and cell type. 
 
SCHWANN CELLS RESPOND TO EXTRACELLULAR ATP 
 Lyons & McCarthy first demonstrated that cultured Schwann cells 
respond to extracellular ATP with increases in intracellular calcium (Lyons et 
al., 1994, 1995).  Similar findings were reported in cultured immortalized SCs 
(Berti-Mattera et al., 1996).  Importantly, it was further shown that purinergic 
receptor expression declines after several days in culture, unless they are co-







(Lyons et al., 1994).  Purinergic receptor expression can be rescued in long 
term SC monocultures by the addition of axon signals.  Although the specific 
types of ATP receptors were not identified, these findings suggest that 
continuous neuron-glia signaling may be necessary for purinergic signaling in 
SCs.   
 There is also evidence that Schwann cells express ATP receptors in 
situ (Mayer et al., 1998).   Interesting phenotypic differences in calcium 
responses have been observed between myelinating and non-myelinating SCs 
in adult nerve following application of selective ATP receptor agonists 
(Mayer et al., 1998).  When and how this phenotypic divergence in receptor 
expression occurs in SCs is not known, and warrants further investigation. 
The presence of these receptors in vivo has also been shown by focal 
application of ATP, which stimulates calcium increases in paranodal 
Schwann cells of mammalian nerve (Wachteler et al., 1996; Lyons et al., 
1995; Mayer et al., 1997), and perisynaptic Schwann cells at the amphibian 
neuromuscular junction (Jahromi, Robitaille, Charlton 1992; Robitaille 
1995).   
   Most cells, including glia, express more than one type of purinergic 
receptors. For example, astrocytes express multiple adenosine ATP receptor 
subtypes, often in the same cell (King et al., 1996; Neary et al., 1998).  A 
similar picture is beginning to emerge for cells of the oligodendrocyte lineage  







are expressed in developing pre-myelinating SCs, or which intracellular 
signaling pathways are activated in response to extracellular ATP. 
 Activation of different purinergic receptor subtypes could activate 
multiple intracellular second messengers and signal transduction pathways.  
Purinergic receptors could also be indirectly linked to other signaling systems, 
including growth factors, neurotransmitters, cell adhesion molecules, 
cytokines, hormones, and others, suggesting that they may be involved in 
many different cellular functions (Ralevic and Burnstock, 1999).  Different 
receptors can have antagonistic actions on other purinergic receptors and 
intracellular signaling pathways in the same cell.  In addition, the downstream 
pathway and biological effects appear to vary widely in different cell types, 
including different types of glial cells.  Diversity of receptor expression and 
developmental and environmental influences likely contribute to these 
differences. For this reason, it will be important to characterize the specific 













Figure 3.   Families of ATP (P2) and Adenosine (P1) receptors. 
P2 receptors divide into two families based on differences in molecular 
structure and signal transduction mechanisms. P2X are ligand-gated ion 
channels and P2Y are G-protein coupled receptors. Adenosine/P1 receptors are 
all coupled to G-proteins and can divided into A1, A2A, A2B, and A3 
subtypes.  Multiple subtypes of each family have been cloned and can be 






























EXPERIMENTAL AIMS  
 This research will specifically test the hypotheses that pre-myelinating 
Schwann cells respond to neural impulse activity, and that activity-dependent 
signaling from axons regulates Schwann cell gene expression and function.  
Major objectives of these studies were to identify the activity-dependent 
signal(s) involved, the functional consequences which ensued, and to 
investigate the specific cellular and molecular mechanisms by which these 
signal(s) regulate Schwann cell function during development. To address 
these questions, a neuron/SC co-culture system equipped with stimulating 
electrodes was used to evoke action potentials in dorsal root ganglion neurons 
(DRGs), and study the ensuing effects in pre-myelinating SCs.  This 
dissertation will examine the following questions: 
 
1. Does activity-dependent communication regulate gene expression in pre-
myelinated SCs? (Chapter 2) 
 
a)   Do Schwann cells detect action potential activity along pre-myelinated 
DRG axons? 
b)   What is the activity-dependent signal? 
c) Does activity dependent signaling regulate gene expression in pre-












                                                                        
 
2.  What are the functional consequences of activity-dependent axon-Schwann 
cell communication?  (Chapters 3 and 4) 
 
a)  Do action potentials and /or ATP regulate SC proliferation? 
b)  Does activity-dependent axon-SC communication and/or ATP regulate SC 
differentiation and/or myelination? 
 c)  Does purinergic signaling regulate the cell cycle in SCs? 
 
3) Which purinergic receptors regulate activity-dependent axon-SC 
communication? (Chapter 5) 
 
a) Which specific purinergic receptors are expressed in developing SCs? 
b) Which signal transduction pathway(s) are activated in response to activity-
dependent release of ATP? 
c) Independent roles of ATP and Adenosine in regulating MAPK pathways in 
developing SCs. 
 28





















 Electrical activity plays a fundamental role in modifying developing 
neural circuits, yet the role of neural impulse activity in regulating glial 
development has not been adequately explored.  It is well established that 
myelinating glia are dependent on axonal signals during embryonic and early 
postnatal development (see review(s) by Mirsky and Jessen, 1996,1998), but 
the specific signals that regulate the timing of glial differentiation and 
myelination have remained elusive. The onset of high frequency action 
potential activity along developing peripheral nerves corresponds to the 
period when Schwann cells are exiting the cell cycle and initiating 
myelination, suggesting that neural impulse activity could serve as an 
important instructive signal regulating Schwann cell (SC) gene expression and 
development.    
 Calcium imaging studies in the central and peripheral nervous systems 
have been used to detect activity-dependent axon-glial communication in the 
postnatal nervous system.  Repetitive firing of action potentials can trigger 
intracellular calcium increases in glia in the frog optic nerve, possibly through 
the release of neurotransmitters or co-transmitters (Kreigler and Chiu, 1993).  







metabotropic glutamate receptors, are a likely candidate.   Astrocytes in culture 
respond to glutamate application (Cornell-Bell et al., 1990) and neuronal 
stimulation (Dani, Chernjavsky and Smith 1992) with a sustained increase in 
intracellular calcium.    
In the peripheral nervous system (PNS), studies at the frog 
neuromuscular junction have demonstrated that repetitive stimulation causes 
an elevation of intracellular calcium in perisynaptic Schwann cells (Jahromi et 
al., 1992; Reist and Smith 1992), possibly mediated by the release of 
acetylcholine or ATP (Robitaille 1995) from the nerve terminal.  Calcium 
responses were not detected in other Schwann cells along the myelinated axon 
(Jahromi et al., 1992; Reist and Smith, 1992), or in unmyelinated nerves 
(Wachteler et al.,1998), suggesting that this signaling may be limited to 
functions associated with synaptic transmission.   
Activity-dependent calcium transients have also been detected in the 
paranodal loops of myelinated Schwann cells of the frog sciatic nerve in 
response to longer duration and higher frequency stimulation (Lev-Ram et al., 
1995).  The authors suggested that an increase in concentration of extracellular 
potassium at the node of Ranvier could depolarize voltage-sensitive calcium 
channels on the paranodal Schwann cells.  
Glia along PNS and CNS axons express a variety of receptors and 
channels that could in theory mediate communication between axons and glia 







nerve and white matter glia respond to glutamate, adenosine, ATP, histamine, 
acetylcholine, serotonin, and potassium with increases in intracellular calcium 
(Bernstein et al., 1996; Kreigler and Chiu, 1993).  Schwann cells in vitro and 
in situ are also responsive to many of these neuroactive substances.  (Lyons et 
al., 1994;Yoder at al., 1992; Jahromi et al., 1992: Lev-Ram et al.,1992).   
Possible activity-dependent communication between axons and pre-
myelinating Schwann cells during development is less well studied.  It is 
uncertain whether there is sufficient activity-dependent release of 
neurotransmitters from extrasynaptic regions of premyelinated axons to 
influence premyelinating Schwann cells, or whether extracellular potassium 
concentration would be increased as it is at the node of Ranvier, where 
potassium channels are concentrated in the paranodal region and where 
extracellular space is limiting to diffusion.   
Various functions have been proposed for activity-dependent 
interactions between axons and glia in the nervous system (Smith 1998), 
including buffering extracellular potassium (Lev-Ram et al., 1995; Lieberman  
1991), modulating neurotransmitter release at the synapse (Jahromi et al. 1992; 
Reist and Smith, 1992; Robitaille 1998), regulating synaptic structure 
(Trachenberg and Thompson 1997), and the excitability of neurons (Newman 
and Zahs, 1998).  During development, activity-dependent axon-glial 
communication has been proposed to influence glial proliferation (Barres and 







review by Zalc and Fields, 1999), but the activity-dependent signals involved 
have remained elusive.  In premyelinated axons, which lack both nodes of 
Ranvier and synapses, action potential activity might influence Schwann cells 
to regulate survival, proliferation, or differentiation to meet functional 
requirements during development, but direct evidence is lacking. 
The present study focuses on the following questions: (1) Can 
premyelinating Schwann cells detect action potentials from axons? (2) How is 
action potential activity transmitted to premyelinating Schwann cells? (3) What 
intracellular signaling molecules are involved?  (4) Is gene transcription in 










ELECTRICAL STIMULATION.   
 Neurons were dissociated from the DRG of fetal mice and cultured for 
three weeks in multi-compartment chambers equipped for electrical 
stimulation (Fields et al., 1992).  Axons grew into the central compartment by 
passing beneath high resistant barriers separating two side compartments.  This 
allowed electrical stimulation of DRG neurons at various frequencies (1-10 
Hz) and patterns (0.5 sec bursts at 10 Hz every 2 sec) with brief pulses (200 
nsec, biphasic pulses at 5 V) from a custom made multi-channel stimulator. 
The stimulus was monitored continually by an oscilloscope and by light 
emitting diodes in series with stimulating electrodes in each dish. Up to 24 
cultures could be stimulated simultaneously inside the incubator. 
Electrophysiological recording in DRG neurons labeled with DiI show that 
only those neurons with axons traversing the barrier are stimulated to fire 
action potentials (Li et al., 1996)  
 
CELL CULTURE.   
 DRG neurons were obtained from embryonic day 13.5 mice and plated 
at a density of 0.35x106 cells/ml into the side compartments of multi-
compartment chambers. DRG cultures were maintained in medium containing 







nerve of postnatal mice (P2) and cultured and purified using the Brockes 
method (Kleitman et al., 1991) with the following modifications: Schwann 
cells were cultured in medium containing 5% horse serum, and purified after 1 
week using anti-Thy1.1 and complement to lyse contaminating fibroblasts.  
Purified Schwann cells were maintained in 5% horse serum medium, without 
exogenous growth factors or mitogens until used in monoculture or co-cultured 
into the side compartments (30,000 cells / side) of chambers containing 3-week 
old DRG neurons.  Schwann cells in co- and monoculture, were in culture 48-
72 hours and incubated overnight in serum-free medium prior to all 
experiments.  
 
CALCIUM IMAGING.  
  Intracellular Ca2+ was monitored in Schwann cells co-cultured for 48-
72 hours with DRG neurons that were stimulated to fire action potentials in 
multi-compartment chamber preparations.  Confocal microscopy (BioRad 
MRC 1024) with the calcium-sensitive indicator fluo-3 (Molecular Probes, 
Eugene, OR) was used to measure changes in fluorescence intensity (∆F/Of) 
due to calcium transients in Schwann cells, DRG axons and cell bodies. 
Measurements were carried out at room temperature in a HEPES-buffered 
balanced salt solution, pH 7.2.  A Nikon 40 X , 0.7 n.a. long-working distance 
lens was used for confocal imaging of cells grown on plastic dishes. A 40X 







coverslips.  Scanning argon ion or krypton-argon lasers emitting at 488 nM 
were used for excitation, and imaged with a pin-hole setting of 3.2-4.5mm.  
The optical sectioning by confocal microscopy allowed us to distinguish 
calcium responses in Schwann cells from responses in neurons and axons.  
Calcium transients were also measured in Schwann cells growing 24-72 hour 
in monoculture in response to candidate signaling molecules ATP (Mol. 
Probes), glutamate (Sigma), and potassium chloride (60mM).  
 
ATP MEASUREMENTS.    
 ATP was measured in medium collected from DRG cultures using a 
luciferin/luciferase biolumunescence assay (Molecular Probes, Eugene, OR) 
and a luminometer (EG&G, Berthold, Germany).  The growth medium was 
replaced with serum and NGF free medium 2 hours before collecting 
conditioned medium from the side compartments of control DRG cultures or 
cultures stimulated for 30 min at different frequencies (0.1-10 Hz).  Culture 
medium was also collected from purified Schwann cells growing in the side 
compartments without neurons following 10 Hz stimulation.  Experimental 









IMMUNOCYTOCHEMISTRY.   
 Schwann cell/DRG co-cultures (as well Schwann cells in monoculture) 
were stimulated electrically or pharmacologically and fixed immediately (for 
P-CREB, P-MAPK) or after 1 hour (for c-Fos, Krox-24, Krox-20) with 1% 
paraformaldehyde.  Cells were permeabilized with 0.2% Triton X-100 and 
non-specific peroxidases were blocked with 3% hydrogen peroxide, followed 
by a 3% normal goat serum block.  Cultures were incubated with antibody 
against CREB phosphorylated at Ser-133 (1:800, New England Biolabs), 
phosphorylated MAPK (1:800, New England Biolabs), c-Fos (1:200, 
Calbiochem), Krox-20, and Krox-24 (1:200 – 1:1000, Santa Cruz) for 1 hour at 
room temperature. Cultures were then incubated with biotinylated goat anti-
rabbit antibody (Vector Labs), and localized with the ABC method.  The 
relative intensity of the stain was quantified by using image densitometry on a 
video microscope (Image-1, Universal Imaging).  Immunocytochemical 
detection of S-100 (Sigma, 1:500) was performed according to the above 
protocol but was detected with fluorescein-conjugated goat F(AB’)2 fragment 
to mouse IgG (Cappel, Aurora, OH) at a 1:200 dilution.   
 
 
EXPERIMENTAL DESIGN AND DATA ANALYSIS.   
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 The relative intensity of nuclear staining after immunocytochemistry 
was compared by imaging densitometry from multiple culture dishes 






acquired from at least 15 randomly chosen fields in each culture using a 
Nuvicon video camera and digitized on an 8-bit scale for storage and optical 
densitometry using Image-1 software (Universal Imaging, West Chester, PA).  
Statistical analysis was based on the mean staining intensity of nuclei in each 
dish, determined from measurements of all Schwann cell nuclei in each field 
(thus, n = number of cultures).  All values were normalized to the mean 
nuclear staining intensity of control cultures in each experiment to allow 
pooling of replicate experiments [arbitrary O.D. units = (nuclear staining 
density/average staining density of control nuclei) X 100) – 100).  This yields a 
scale of 0-55 O.D. units from gray (unstimulated control) to pure black (Fields 
et al., 1997).  The results were presented as mean +- SEM, and statistical 
comparisons were evaluated by ANOVA or two-sample t-test using the 










Confocal calcium imaging was used to determine whether neural 
impulse activity can be detected by premyelinating Schwann cells.  Changes in 
intracellular calcium were measured in Schwann cells co-cultured with DRG 
neurons that were stimulated to fire action potentials in a multi-compartment 
chamber preparation equipped with stimulating electrodes (see fig. 4A).  This 
culture preparation contained purified Schwann cells from the sciatic nerve of 
mice, co-cultured for 48-72 hours with a pure population of mouse DRG 
neurons that had been in culture for 3 weeks.  Schwann cells displayed a 
spindle-shaped morphology, were S-100 positive and were just beginning to 
express the 04 antigen.  DRG axons were stimulated at different frequencies 
(1-10 Hz) and changes in fluorescence intensity of the calcium indicator fluo-3 
were measured.  Optical sectioning by confocal microscopy permitted 
unambiguous distinction of Ca 2+ responses in Schwann cells from those in 
neurons and axons.  
  Cytoplasmic Ca 2+ levels increased sharply in DRG neurons and axons 
with the onset of 10 Hz stimulation, as would be expected from depolarization 
of the membrane by sodium-dependent action potentials and activation of 
voltage-sensitive calcium channels.  Within 15 – 150 sec of stimulus onset, 
intracellular calcium levels in several Schwann cells in each microscopic field 







concentration dynamics of the calcium response varied in different Schwann 
cells, from a sustained increase to a single or repetitive low frequency 
oscillation in calcium concentration.  The oscillations outlasted the duration of 
the stimulus by several minutes in some cells.  These responses were seen in 
response to a wide range of stimulus frequencies within the normal 
physiological range.  From 1 Hz stimulation (the lowest frequency tested) to 10 
Hz, the calcium response in Schwann cells varied proportionately with the 
stimulus frequency.  The initial slope of the calcium increase in Schwann cells 
was steeper in response to higher frequency stimulation; more cells in the field 
showed responses; the peak amplitude of the calcium increase was higher, and 
the latency between the neuronal and SC response was shorter than for lower 
frequency stimulation (Fig. 4C, c vs. a,b).  These results demonstrate that pre-
myelinating Schwann cells are able to detect neural impulse activity well 
within the normal physiological range of firing, and Schwann cells are 
sensitive to different frequencies of action potentials.   
The delay between the Schwann cell and neuronal response suggests 
involvement of a soluble signaling molecule released from axons in an 
activity-dependent manner to stimulate an increase in intracellular calcium in 
Schwann cells. Bath application of glutamate to purified Schwann cells failed 
to elicit a calcium response over a wide range of concentrations (10-600 µM), 
indicating that activity-dependent release of this neurotransmitter from DRG 








Figure 4.   Activity-dependent communication between axons and pre-
myelinating Schwann cells. 
A. Mouse DRG axons growing beneath high resistance barriers of 
multicompartment cell culture chambers were stimulated by current pulses 
delivered through platinum electrodes.  Schwann cells (SC) were plated on 
mouse DRG neurons (N) that were grown in culture for 3-weeks.   
B.  Action potentials in premyelinated axons increase intracellular Ca2+ in 
SCs.  Scanning laser confocal microscopy was used to monitor changes in 
intracellular Ca2+ in SCs and DRG neurons in co-culture, using the fluorescent 
Ca2+ indicator fluo-3/AM.  Action potentials induced an immediate influx of 
Ca2+ through voltage-sensitive Ca2+ channels in DRG neurons (arrow)(34 s).  
This was followed 15 to 150 s later by an increase in intracellular Ca2+ 
concentration in multiple SCs (*) (48 and 82 s).  
C The Ca2+ responses for individual cells in (B) are plotted in (C) after 
stimulation at different frequencies (1-10 Hz).  Note that Ca2+ increased in 
DRG neurons (black traces) immediately upon stimulation, but responses in 
SCs (color traces) were delayed and proportionate to the stimulus frequency 


















 Depolarization with 60 mM KCl did increase intracellular calcium 
levels in a number of Schwann cells, consistent with the reports of voltage-
sensitive calcium channels in these cells. (Ritchie et al., 1991).  It is doubtful 
however, whether axonal stimulation at the low frequencies tested, for example 
60 action potentials at 1 Hz, could produce sufficient increases in extracellular 
potassium concentration to depolarize Schwann cells and trigger the calcium 
response.  
Schwann cells express P2-purinergic receptors, and ATP has been 
shown to elicit calcium responses in astrocytes, (Guthrie et al., 1999, Neary et 
al., 1991) oligodendrocytes, (Bernstein et al., 1996; Takeda et al., 1995) and 
myelinating and non-myelinating Schwann cells (Ansselin, et al, 1997;Green et 
al., 1997; Jahromi et al., 1992; Lyons et al. 1994, 1995; Mayer et al., 1997; 
Berti-Mattera et al., 1996; Verhraysky and Kettenman, 1996).  Bath 
application of ATP (10 nM-1mM) to Schwann cells in monoculture induced a 
large increase in intracellular Ca2+ followed by sustained low frequency 
oscillations (see fig. 5A), which closely modeled the activity-induced response.   
To test whether the activity-dependent calcium fluxes in Schwann cells 
were caused by ATP released from stimulated axons, Schwann cell calcium 
responses were measured in response to 10 Hz stimulation in co-culture with 
neurons in the presence of apyrase, an enzyme which degrades extracellular 
ATP to AMP (Guthrie et al., 1999).  Before the application of apyrase, DRG 







intracellular calcium levels were elevated in a number of Schwann cells (see 
fig. 5Ba).  Stimulation of the same field 45 minutes later in the presence of 30 
U/ml apyrase completely blocked the calcium response in Schwann cells, but 
had no effect on the electrically-induced increase in intracellular calcium in 
DRG axons and cell bodies (Fig. 5Bb). Together, these results fail to support 
an alternative hypothesis that potassium or other diffusible molecules 
contributed to the activity-dependent calcium response measured in these 
Schwann cells, and implicate ATP as the intercellular signaling molecule.   
 To determine whether ATP is released extrasynaptically from DRG 
axons in an activity-dependent manner, conditioned medium collected from 
stimulated and control DRG cultures was assayed using the sensitive 
luciferase-bioluminescence ATP assay (Molecular Probes).  Medium collected 
from DRG neurons stimulated at 10 Hz for 30 min showed a highly significant 
increase in ATP compared with unstimulated controls (n=69 experiments, 
p<<0.004) (Fig. 6A).  A standard curve, calculated by linear regression of 
luciferase activity against a series of known ATP concentrations (r2 = 0.99) 
indicates approximately 14.5 nM ATP in the stimulated cultures.  This activity-
dependent increase in ATP was completely blocked following 10 Hz 
stimulation in the presence of 1µM tetrodotoxin (TTX) which blocks sodium-
dependent action potentials (see fig. 6A). Constant frequency stimulation was 
not required; a phasic pattern of stimulation (0.5 sec bursts @10 Hz every 2 







with unstimulated controls (n=57 experiments, p<0.022 ). Stimulation of DRG 
at lower frequencies (0.1 Hz, 30 minutes) failed to show this effect (ANOVA 
0, 10 Hz, phasic, 10Hz + ttx, n = 102 experiments, p<<0.003 (Fig. 6A).   
 A timecourse experiment was performed to determine the kinetics of 
ATP release from DRG neurons.  Electrical stimulation induced a rapid and 
substantial increase in ATP within the first 5 minutes electrical stimulation, 
which declined significantly by 30 minutes (Fig. 6B).  To test whether the 
source of ATP was neuronal, purified Schwann cells in monoculture were 
stimulated at 10 Hz for 30 minutes or depolarized with 60 mM KCl. There 
were no changes in ATP levels with either stimulus compared with controls 
(data not shown), indicating that Schwann cell are unable to release detectable 
levels of ATP in response to electrical depolarization, and they are not the 
source of ATP in co-cultures stimulated electrically.  Furthermore, significant 
activity-dependent release of ATP was observed in the central axonal 
compartment of the chamber preparation, which lacked DRG cell bodies, 







Figure 5.   Extracellular ATP mediates activity-dependent communication 
between neurons and SCs 
A.  Functional ATP receptors linked to Ca2+ signaling were detected by 
intracellular calcium imaging in premyelinating Schwann cells (SCs) 
monocultures in response to ATP (10µM). 
B.  In SCs the action potential-induced increase in intracellular Ca2+ (color 
traces in a) was blocked by electrical stimulation in the presence of 30 U/mL 
apyrase (b), but Ca2+ responses in DRG neurons (black traces) were not 
affected.     Bar = 20 µM. 
 
Figure 6.  Extrasynaptic ATP release from electrically stimulated DRG 
neurons. 
A.  ATP, measured by luciferase activity assay, increased significantly in 
medium from DRG cultures stimulated at 10 Hz or in a phasic pattern (0.5 s 
bursts @ 10 Hz every 2 sec), but this was blocked by stimulation in the 
presence of the sodium channel blocker TTX.   
B. Electrical stimulation (10 Hz) induced a rapid and substantial increase in 
extracellular ATP within the first 5 minutes stimulation, which declined 
significantly by 30 minutes. 
C. Significant activity-dependent release of ATP was measured from culture 
medium collected from the side (cell bodies + axons) and central 






















 Calcium signals can induce long-term cellular responses by regulating 
the function of several transcription factors, thus leading to the induction of 
late-onset genes.  cAMP response element binding protein (CREB) is an 
important transcription factor mediating calcium-dependent gene expression.  
Using a phospho-specific antibody, we observed that phosphorylation of 
CREB (P-CREB) at the regulatory site, Ser-133, was significantly increased in 
Schwann cells on axons stimulated at 10 Hz compared with unstimulated 
controls (p<<0.001, n=28 exps) (see fig. 7A, a and c).  This effect was 
completely blocked by stimulation in the presence of 1µM TTX (Fig. 7B).  
Levels of P-CREB were elevated significantly by 30 min of stimulation, and 
returned to basal levels within 90 minutes after stopping stimulation (p < 
0.001; n = 17 exps) (Fig. 7B).  A phasic pattern of stimulation (0.5 sec bursts 
@ 10 Hz every 2 sec) delivered for 30 min also significantly increased P-
CREB levels in Schwann cells (Fig 7B).  At least two signaling pathways are 
involved in the phosphorylation of CREB in Schwann cells on electrically-
stimulated axons.  Electrical stimulation in the presence of the CaM kinase 
inhibitor KN62, or in the presence of the MEK-1 inhibitor PD098059, 
significantly inhibited CREB phosphorylation in Schwann cells relative to 
controls stimulated at 10 Hz (p < 0.000, n = 16 exp for KN62 and n = 14 
experiments for PD098059) .   
 Several lines of evidence suggest that phosphorylation of CREB 







release of ATP from axons.  ATP of various concentrations (10nM-100µM) 
applied to purified Schwann cells in mono and DRG co-cultures caused a dose-
dependent increase in CREB phosphorylation (ANOVA 0 µM, 10 µM, 
100µM, n = 8, p<0.023) (see fig. 8A), and 10nM ATP, which we have shown 
to increase intracellular calcium levels in Schwann cell, significantly increased 
P-CREB levels compared with unstimulated controls (n=6, p<0.024).  
Electrical stimulation in co-cultures in the presence of apyrase, which degrades 
extracellular ATP (27 U/ml), blocked the increase in CREB phosphorylation in 
Schwann cells but not neurons, as did pre-incubation in 30 µM suramin, a 












Figure 7.   Neural impulse activity phosphorylates CREB in associated 
pre-myelinating Schwann cells. 
A.  Electrical stimulation of DRG axons caused phosphorylation of CREB (c) 
compared with unstimulated co-cultures (a).  Responses to forskolin (b) was 
used as a positive control.  The staining intensity of Schwann cells was 
compared quantitatively by imaging densitometry.  
B.  CREB was phosphorylated to significantly higher levels in Schwann cells 
on axons stimulated at 10 Hz or in a phasic pattern (0.5 s pulses @ 10 Hz 
every 2 s), but this response was blocked by stimulation in the presence of 
TTX.  Levels of CREB phosphorylation returned to baseline 60 min. after 
stopping axonal stimulation. 
 
Figure 8.  Activity-dependent CREB phosphorylation is mediated by 
extracellular ATP. 
A. ATP of various concentrations (10nM-100µM) applied to purified Schwann 
cells in mono and DRG co-cultures caused a dose-dependent increase in CREB 
phosphorylation 
B. CREB phosphorylation in Schwann cells in response to axonal stimulation 
at 10 Hz was blocked by stimulation in the presence of the P2Y receptor 
antagonist suramin (surm) or the enzyme apyrase (apyr), which degrades 






















 Activity-dependent regulation of gene expression in Schwann cells 
could have important implications during development and regeneration, when 
impulse activity plays an important role.  The promoter region of the 
immediate early gene c-fos, which has been implicated in adaptive responses 
of cells to extracellular stimulation, contains one CRE that binds CREB (Sheng 
et al., 1990). The c-fos gene codes a transcription factor that binds to AP-1 
sites regulating transcription of several late onset genes.  Acute application of 
ATP (30 min) significantly increased c-fos mRNA in purified SCs (see fig 
9A).  Using immunocytochemical staining, we found that c-Fos levels in nuclei 
of Schwann cells were increased significantly in neuronal cultures stimulated 
at 10 Hz for 30 min, and this effect was completely blocked when stimulation 
was performed in the presence of 27U/ml of apyrase (Fig. 9C) (p < 0.000; n = 
30 exp). In addition, application of exogenous ATP (100µΜ) also induced c-
Fos expression in purified Schwann cells (Fig. 9C).   
 The zinc-finger transcription factor krox-24 is expressed in non-
myelinating Schwann cells, where it has been implicated in the control of 
proliferation and differentiation of Schwann cells (Topilko et al., 1997).  Krox-
24 has an AP-1 site in its promoter region, and experiments in striatal and 
neocortical neurons (Dragunow et al., 1994) report that expression of krox-24 
is blocked by antisense oligonucleotides against c-fos.  Direct stimulation of 
purified SC monocultures with ATP (100µM, 30 min) resulted in a significant 







Importantly, we found that DRG axons firing at 10 Hz for 30 min significantly 
up-regulated nuclear Krox-24 protein levels in Schwann cells, and this activity-
dependent increase was blocked with apyrase (Fig.9B, C).  In addition, 
Schwann cells in monoculture stimulated with 100 µM ATP for 15 min 
significantly increased Krox-24 protein levels (Fig. 9C).  Interestingly, another 
zinc-finger transcription factor, Krox-20, has been reported to have a 
reciprocal pattern of expression to Krox-24 during development of Schwann 
cells. Stimulation of DRG neurons at 10 Hz and with ATP increased 
expression of Krox-24, but it failed to induce expression of Krox-20 in 







Figure 9.  Action potentials induce gene expression in SCs by the release of 
ATP.   
A. ATP (100µM, 15 minutes) stimulates expression of c-fos and krox-24.  The 
ATP-induced increase in mRNA transcripts for both genes is shown by RT-
PCR. 
B Immunocytochemical staining for  Krox 24 expression in DRG/Schwann 
cell co-cultures was increased significantly in Schwann cells in response to 100 
µM ATP (b), or axonal stimulation (c). 
C.  Immunocytochemical staining for c-Fos (black bars) and Krox-24 (grey 
bars), showed an increase in nuclear expression of these genes in SCs on 
axons stimulated 30 min at 10 Hz (10 Hz) compared with unstimulated axons 
(0 Hz).  Direct application of ATP (100 µM, 15 min) stimulates expression of 
both genes (+ ATP), and electrical stimulation in the presence of the ATP-
degrading enzyme apyrase (27 U/mL) blocks the response (10 Hz + apy).  No 
increase in a gene associated with myelinating phenotype, Krox-20, was 
detected in SCs in response to electrical stimulation or ATP application (data 
not shown).  For Krox-24, p = 0.000, one-way ANOVA, n = 28; *p < 0.005 vs. 


















 The present observations indicate that ATP can act as an activity-
dependent signal between premyelinated axons and Schwann cells.  ATP is 
released non-synaptically from DRG neurons in a frequency-dependent 
manner, and it acts on Schwann cell purinergic receptors to increase 
intracellular calcium to regulate the transcription factor CREB and expression 
of c-fos and Krox-24 genes in Schwann cells.   
 
ATP AS AN AXON-SCHWANN CELL SIGNALING MOLECULE 
Activity-dependent release of ATP has been detected from synaptic 
terminals (Wieraszko et al., 1989; Von Kugelgen et al., 1998), but ATP release 
from non-synaptic regions of myelinated, unmyelinated or premyelinated 
axons has not been shown previously.  Release of the neurotransmitter 
glutamate from non-synaptic regions of axons has been detected in response to 
electrical stimulation of frog sciatic nerve (Weinreich and Hammerschlag, 
1975;Wheeler et al., 1965) and optic nerve (Weinreich and Hammrschlag, 
1975), and activity-dependent non-synaptic release of adenosine has also been 
shown in studies if the rabbit vagus nerve (Maire et al., 1984).  At the NMJ, 
electrically-induced calcium responses in perisynaptic Schwann cells are 
inhibited by exogenous ATP or P2 receptor antagonists (Robitaille, 1995), 







CNS, intense stimulation of brain slices has been reported to release ATP non-
synaptically (Hamann and Atwell 1996), but this has been interpreted to be a 
result of neural injury, because the ATP release required intense stimulation 
(70- 100 V at 70 – 300 Hz) and release was not blocked by TTX.  In the 
present experiments, action-potential-dependent ATP release was measured 
directly from DRG cultures that lack synapses.  There is no evidence that 
stimulation of these cultures for up to 5 days causes neuronal injury or death 
(Itoh et al., 1995).  In contrast to the hippocampal slice studies, minimal 
stimulation intensity (5V), frequency (1 Hz), and duration (1 min) induced the 
calcium response, and blocking sodium-dependent action potentials with TTX 
prevented the release of ATP and phosphorylation of CREB.   
 Schwann cells in vitro and in vivo express purinergic (P2) receptors 
which are linked to intracellular calcium stores and other signal transduction 
pathways (Ansselin et al., 1997; Berti-Mattera et al., 1996; Green et al., 1997; 
Lyons et al., 1995; Verkhratsky and Kettenman, 1996). Studies of biopsied 
human peripheral nerve (Wachteler, Mayer et al., 1996, Mayer, Quasthoff, 
Grafe 1998), and excised mammalian peripheral nerve indicate the presence of 
purinergic receptors on Schwann cells (Mayer, Wuasthoff, Grafe 1998; Mayer, 
Wachtler, Kamleiter, Grafe 1997); with the P2Y2 subtype predominating on 
myelinating Schwann cells and the P2Y1 subtype on non-myelinating Schwann 
cells (Mayer, Quasthoff, Grafe, 1998). The receptors are lost over several days 







loss (Lyons, Morell, McCarthy 1994, 1995).  In the present study, bath 
application of ATP to Schwann cell mono and co-cultures elicited a robust 
calcium response, indicating that the majority of Schwann cells in our system 
had not lost the ATP receptors.  The presence of these receptors in vivo has 
also been shown by focal application of ATP, which stimulates calcium 
increases in paranodal Schwann cells of mammalian nerve (Wachteler et al., 
1996; Lyons et al., 1995; Mayer et al., 1997), and perisynaptic Schwann cells 
at the amphibian neuromuscular junction (Jahromi, Robitaille, Charlton 1992; 
Robitaille 1995).   
 
INTRACELLULAR SIGNALING FROM ACTION POTENTIALS 
 The results show that action potentials activate calcium-dependent 
intracellular signaling pathways leading to phosphorylation of the transcription 
factor CREB in Schwann cells.  Although the multiple signaling pathways 
regulating CREB phosphorylation in neurons are understood in some detail, 
comparatively less is known of the mechanisms underlying CREB 
phosphorylation in glia.  The MAPK/RSK pathway can mediate CREB 
phosphorylation in response to calcium, PKC, and growth factors in 
oligodendrocyte progenitor cells (Pende et al., 1996), and PKA activation in 
response to β-adrenergic stimulation can phosphorylate CREB in differentiated 
oligodendrocytes (Sato-Bigbee et al., 1998).  In Schwann cells, axolemma 







neuregulin acting through the MAPK pathway (Tabernerro et al., 1998), can 
phosphorylate CREB.  The possible activity-dependent phosphorylation of 
CREB in glia or ATP-induced activation of this transcription factor in 
Schwann cells has not been investigated previously. 
Three lines of evidence support the hypothesis that the activity-
dependent release of ATP from peripheral axons as the mechanism stimulating 
CREB phosphorylation in premyelinated Schwann cells.  First, the activity-
induced CREB phosphorylation was blocked when purinergic receptors were 
blocked with suramin. Secondly, the activity-dependent effect was blocked 
when we included the ATP-degrading enzyme apyrase in the medium during 
electrical stimulation.  Third, we have found that direct stimulation of Schwann 
cells with ATP, significantly increased P-CREB levels in a dose-dependent 
manner.  The reduced CREB phosphorylation resulting from stimulation in the 
presence of the specific inhibitors of MEK or calmodulin-dependent kinases, 
suggest that both the CaM Kinase and MAPK pathways regulate CREB 
phosphorylation in Schwann cell following neural impulse activity.   
 
REGULATION OF SCHWANN CELL GENE EXPRESSION BY NEURAL 
IMPULSES 
 The regulation of  Schwann cell development is ultimately determined 
by signals from the axon, and identifying transcription factors which may be 
downstream targets of such signals is being actively pursued by a number of 







family (c-Jun, Jun-B and D), CREB, POU domain proteins Oct-6 (SCIP), and 
the zinc-finger proteins Krox -20 and Krox24/Zif268/Egr-1 have been 
associated with Schwann cell proliferation and differentiation (see review by 
Mirsky and Jessen, 1999; Scherer , 1997).  Each of these transcription factors 
has a unique expression pattern in Schwann cells during development, and may 
regulate Schwann cell phenotype through the activation of target genes 
controlling Schwann cell function.  Neural impulse activity begins in DRG 
neurons at about E17 in the rat (Fitzgerald  & Fulton, 1992).  This corresponds 
to the time when pre-myelinated Schwann cells undergo a sharp decrease in 
proliferation and begin to differentiate into either myelinating or non-
myelinating phenotypes (Stewart et al., 1993).  The O4 antigen, which was just 
beginning to be expressed in these Schwann cell cultures, first appears at E16 
in the rat.  Activity-dependent regulation of glial gene expression has been 
detected in the optic nerve (Mack and Chiu, 1994), and in perisynaptic 
Schwann cells at the frog NMJ (Georgiou et al, 1994), but there is no evidence 
to date of activity-dependent regulation of genes in this critical developmental 
period of transition for pre-myelinating Schwann cells. 
 In this study we have shown that axonal stimulation at 10 Hz induces 
the expression of the immediate early gene c-fos in Schwann cells. Stimulation 
of co-cultures in the presence of apyrase (27 U/ml) blocked the activity-
dependent induction of c-fos, and exogenously applied ATP (100uM, 15 min) 







these results suggest that Schwann cell gene expression can be regulated by 
ATP released from DRG axons in an activity-dependent manner. Although c-
Fos may play a role during Wallerian degeneration (Liu et al, 1995), it does not 
yet have an associated function in developing Schwann cells.  c-fos is a stress 
response gene which can respond rapidly to extracellular signals, such as 
action potential activity.  c-Fos can dimerize with Jun proteins to bind to AP-1 
sites of possible intermediate or target genes regulating Schwann cell 
development (proliferation, survival, differentiation, and myelination).   
There is emerging evidence that both krox-20 and krox-24 are 
important regulators of Schwann cell development and differentiation, and c-
fos may have a role in regulating these genes.  c-Fos has been shown to 
suppress the zinc-family transcription factor, krox-20, which contains an AP-1 
site in its promoter  (Gius, D et al., 1990), and that c-fos may be necessary for 
induction of krox-24 in some cells (Dragunow et al., 1994). We have shown 
that stimulation at 10 Hz and with exogenous ATP significantly increases the 
expression of Krox 24 in Schwann cells.  Conversely, stimulation under the 
same conditions fails to increase Krox 20.  krox-24 has been implicated in cell 
proliferation (Topilko et al., 1994), and krox-20 has a critical role in myelin 
formation.  Knock-out of the krox-20 gene leads to complete inhibition of 
compact myelin formation, and the subsequent expression of the myelin genes, 
Po and MBP (Topilko et al, 1994).  Recent work by Zorick et al. has shown 







just prior to myelination, is significantly up-regulated in krox-20 mutants. In 
these mice, Schwann cells are arrested in pro-myelinating stage, they continue 
to proliferate, and undergo increased apoptosis. It was concluded that Krox 20 
controls SCIP expression, and without it, SCIP is incapable of self-down-
regulation.  Krox-24 expression is generally restricted to the non-myelinating, 
proliferating Schwann cells (Topilko et al., 1997).  Interestingly, there is a 
narrow window at birth when the two genes are co-expressed in Schwann cells, 
and it has been suggested (Topilko et al., 1997) that this balance of expression 
between krox-24 and krox-20 may participate in the choice between 
myelinating and non-myelinating pathways. Neural impulse activity, which we 
have shown to up-regulate krox-24 expression, and not krox-20 in 
premyelinating Schwann cells in culture, may serve as one signal influencing 
this phenotypic decision.  Similarly, the action potential-dependent release of 
ATP from premyelinated axons might contribute to regulation of Schwann cell 
proliferation or apoptosis during development.  Future research on activity-
dependent regulation of other genes implicated in phenotypic differentiation of 
Schwann cells will be helpful in providing a better understanding of the 















1. Pre-myelinating Schwann cells can detect action potential activity along sensory 
axons. 
 
2. The activity-dependent signal between axons and pre-myelinating SCs was 
identified as extracellular ATP. 
 
3. Activity-dependent release of ATP phosphorylates CREB, and activates the 














 Extracellular ATP was recently identified as a potent activity-
dependent signal between axons and pre-myelinating Schwann cells (SCs) 
(Stevens and Fields, 2000).  Axonal release of ATP induces calcium transients, 
and gene expression in associated SCs, and thus could serve as an instructive 
signal regulating SC development before the onset of myelination.  One of the 
functional consequences of this activity-dependent axon-SC communication 
could be in regulating SC proliferation.  The onset of high frequency stimulus-
evoked firing along developing sensory axons corresponds to the pre-
myelinating period (Fitzgerald, 1987), when embryonic SCs are undergoing 
dramatic changes in proliferation in response to axon-derived signals.  
 Earlier studies in the developing CNS suggest that electrical activity 
stimulates proliferation of myelinating glia (Barres and Raff, 1993).  Blockade 
of axonal firing in developing optic nerve significantly inhibited 
oligodendrocyte progenitor cell (OPC) proliferation. The mechanism was 
thought to involve activity-dependent release of growth factors (PDGF) from 
neighboring astrocytes; however the activity-dependent axonal signal was not 
identified.  The effects of neural impulse activity on SC proliferation and 







proliferation of other types of glial cells.  Extracellular ATP can potently 
stimulate astrocyte proliferation (Neary et al., 1998; Franke et al., 1999; Neary 
et al., 1999b), both in culture (Rathbone et al., 1992; Abbracchio et al., 1994; 
Neary et al., 1994b) and in vivo (Franke et al., 1999; Franke et al., 2001).  
Activation of ATP/P2 receptors have also been shown to stimulate 
proliferation of Muller glia (Moll et al., 2002; Sanches et al., 2002; Milenkovic 
et al., 2003), as well as microglia, but it is not known whether ATP regulates 
SC proliferation. 
 
REGULATION OF SCHWANN CELL PROLIFERATION 
 SCs continue to divide after migration into peripheral nerves. In vivo 
studies in the rat sciatic nerve demonstrated a rise in SC proliferation between 
E17-19 (Stewart et al., 1993).   Direct contact of SCs with the axolemma, 
sustains SC proliferation until initiation of axon ensheathment, and a number 
of soluble mitogenic signals have been identified (Salzer et al., 1980; DeVries 
et al., 1982; Ratner et al., 1985).  Release of ATP from electrically active 
axons might stimulate SC proliferation directly or indirectly by stimulating the 
secretion of mitogens.   
 While significant progress has been made in identifying factors that 
stimulate Schwann cells to divide, much less is known about the extracellular 
signals that inhibit SC proliferation in vivo, and in vitro. Just before birth, pre-







a requisite for induction of SC differentiation and myelination (Asbury, 1967; 
Stewart et al., 1993).   Mechanisms that arrest SC proliferation could indirectly 
regulate myelination by enabling SCs to respond to myelin-inducing signals at 
the appropriate time.  In vivo recordings from embryonic rat DRG neurons 
reveal that the onset of low frequency stimulus-evoked firing (10-20 Hz) 
occurs ~E17, and the frequency of firing,  and the total number of impulses 
increase steadily between E17 and birth (Fitzgerald, 1987), when pre-
myelinating exit the cell cycle and differentiate into myelinating or non-
myelinating phenotypes.  A specific aim of this research was to determine 
whether action potential activity can influence SC proliferation at the pre-
myelination stage, and determine whether ATP release from electrically active 
axons could be involved. 
 
 
REGULATION OF NUCLEAR CELL CYCLE PROTEINS IN GLIA 
 Major progress has been made in understanding the signals and 
proteins involved in the regulation of the cell cycle in oligodendrocyte 
progenitor cells (OPCs), astrocytes, and more recently, Schwann cells (Stevens 
and Fields, 2002). Cell proliferation is regulated by coordinated interactions 
between multiple proteins at distinct phases of the cell cycle.  The three 
principal players are the cyclins, (D, E, A and B), cyclin-dependent kinases 







  Growth factors and axonal mitogens stimulate quiescent glial cells to 
enter the G1 phase of the cell cycle by inducing expression of the D-type 
cyclins.  These cyclins subsequently assemble with their catalytic partners, the 
cyclin-dependent kinases (cdk4 or cdk6). Cyclin D-cdk complexes are required 
for G1 progression, and serve to couple cell cycle machinery with extracellular 
signals. The sequential activation of different Cdks coordinates the orderly 
progression through the cell cycle. Negative regulation of the cell cycle is 
mediated by two families of cyclin-dependent kinase inhibitors (CKIs), the 
Cip/Kip family (p21, p27 p57) or Ink family (p15, p16, p18, p19) (Sherr and 
Roberts, 1999).  All of these proteins bind and inhibit specific cyclin-Cdk 
complexes, giving an additional level of control of the cell cycle.  Transition 
from G1 into S phase (DNA synthesis phase) is a critical cell cycle restriction 
point in glial cells.  Progression to S phase in Schwann cells and OPCs 
requires formation and activation of cyclin-Cdk complexes (Tikoo et al., 2000; 
Ghiani and Gallo, 2001), and the subsequent phosphorylation (inactivation) of 
the retinoblastoma protein (pRb). CKIs can prevent entry into S phase, and 
induce cell cycle arrest or exit by binding to these G1 cyclin-Cdk complexes.   
 While there is growing evidence that purinergic signaling molecules 
regulate glial proliferation, it is not known whether activation of purinergic 
receptors regulates proteins that directly control cell cycle progression. The 
present study uses a DRG/SC co-culture system equipped with stimulating 







Schwann cell proliferation and, if apparent determine which aspects of cell 









Figure 10.   Glial cell proliferation is regulated by coordinated interactions 
between multiple proteins at distinct phases of the cell cycle.  
The cyclins (D, E, A and B) assemble with their catalytic partners, the cyclin-
dependent kinases (Cdk2, 4, 6 and cdc2), which are positively regulated by 
cyclin-cdk activating kinases (not shown), and via the serine/threonine 
phosphatase, cdc25.  Negative regulation is mediated cyclin-dependent kinase 
inhibitors (CKIs), from the INK4 or Cip/Kip family, which bind to cyclin/cdk 
complexes. Progression to S phase requires the phosphorylation (inactivation) 
of retinoblastoma protein (pRb) by cyclinE-cdk2, which permits the E2F 







   
METHODS 
 
CELL CULTURE.   
 DRG neurons were obtained from embryonic day 13.5 mice and plated 
at a density of 0.35x106 cells/ml into the side compartments of 
multicompartment chambers. DRG cultures were maintained in medium 
containing 50ng/ml nerve growth factor (NGF).   Schwann cells, obtained from 
the sciatic nerve of postnatal mice (P2) were cultured and purified using the 
Brockes method (Kleitman et al., 1991) with the following modifications: 
Schwann cells were cultured in medium containing 5% horse serum, and 
purified after 1 week using anti-Thy1.1 and complement to lyse contaminating 
fibroblasts.  Purified Schwann cells were maintained in 5% horse serum 
medium, without exogenous growth factors or mitogens until used in 
monoculture or co-cultured into the side compartments (30,000 cells / side) of 
chambers containing 3-week old DRG neurons.  Schwann cells in co- and 
monoculture, were in culture 48-72 hours and incubated overnight in serum-
free medium prior to all experiments.  
 
ELECTRICAL STIMULATION.   
 Neurons were dissociated from the DRG of fetal mice and cultured for 







(Fields et al., 1992).  Axons grew into the central compartment by passing 
beneath high resistant barriers separating two side compartments.  This 
allowed electrical stimulation of DRG neurons at various frequencies (1-10 
Hz) and patterns (0.5 sec bursts at 10 Hz every 2 sec) with brief pulses (200 
nsec, biphasic pulses at 5 V) from a custom made multi-channel stimulator. 
The stimulus was monitored continually by an oscilliscope and by light 
emitting diodes in series with stimulating electrodes in each dish. Up to 24 
cultures could be stimulated simultaneously inside the incubator. 
Electrophysiological recording in DRG neurons labeled with DiI show that 
only those neurons with axons traversing the barrier are stimulated to fire 
action potentials (Li et al., 1996). 
 
PROLIFERATION ASSAY 
 SCs were co-cultured with DRG neurons, and axons were electrically 
stimulated at 10 Hz for 1-24 hrs.  Purified SCs 48 hours in monoculture were 
serum starved for 18-24 hours before treatment with growth factors (10ng/mL 
PDGF or 250ng/mL B heregulin + 2µM forskolin) +/- ATP).  Co and mono-
cultures were pulsed with BrdU (Boehringer Mannheim) for 6 hrs, fixed and 
stained according to manufacturer instructions. Cultures were then 
counterstained with Hoechst nuclear stain (Molecular Probes) at a dilution of 
1:2000 for 10 min. Proliferation rate was calculated as the ratio of 








with BrdU and Hoechst were counted in each microscope field.  10-15 
randomly chosen fields were sampled to obtain a mean for each culture well; n 
= number of culture wells. 
 
TUNEL ASSAY  
 
 For the apoptosis assay, SCs were fixed with 4% paraformaldehyde for 
1 hour following treatment.  Cells were stained for TUNEL according to 
manufacturer’s protocol (Roche), and the % of TUNEL-positive cells was 
determined from the ratio of TUNEL/Hoechst-positive cells/microscope field. 
 
IMMUNOCYTOCHEMISTRY.   
 Schwann cell/DRG co-cultures (as well Schwann cells in monoculture) 
were stimulated electrically or pharmacologically and fixed immediately with 
1% paraformaldehyde.  Cells were permeabilized with 0.2% Triton X-100 and 
non-specific peroxidases were blocked with 3% hydrogen peroxide, followed 
by a 3% normal goat serum block.  Cultures were incubated with antibody 
against cyclin D1, Cyclin E (1:100) p21 and p27 (Santa Cruz 1:500) for 1 hour 
at room temperature. Cultures were subsequently incubated with biotinylated 
goat anti-rabbit antibody (Vector Labs), and localized with the ABC method. 
The relative intensity of the stain was quantified by using image densitometry 
on a video microscope (Image-1, Universal Imaging).  Immunocytochemical 
detection cyclin D was detected with fluorescein-conjugated goat F(ab’)2 








EXPERIMENTAL DESIGN AND DATA ANALYSIS.   
 The relative intensity of nuclear staining after immunocytochemistry 
was compared by imaging densitometry from multiple culture dishes 
representing controls and all relevant experimental treatments.  Images were 
acquired from at least 15 randomly chosen fields in each culture using a 
Nuvicon video camera and digitized on an 8-bit scale for storage and optical 
densitometry using Image-1 software (Universal Imaging, West Chester, PA).  
Statistical analysis was based on the mean staining intensity of nuclei in each 
dish, determined from measurements of all Schwann cell nuclei in each field 
(thus, n = number of cultures).  All values were normalized to the mean 
nuclear staining intensity of control cultures in each experiment to allow 
pooling of replicate experiments [arbitrary O.D. units = (nuclear staining 
density/average staining density of control nuclei) X 100) – 100).  This yields a 
scale of 0-55 O.D. units from gray (unstimulated control) to pure black (Fields 
et al., 1997).  The results were presented as mean +- SEM, and statistical 
comparisons were evaluated by ANOVA or two-sample t-test using the 










ACTIVITY-DEPENDENT ATP RELEASE INHIBITS SCHWANN CELL 
PROLIFERATION 
 To determine the effects of impulse activity on SC proliferation, pre-
myelinating SCs were co-cultured with DRG neurons for 2 days, and SC 
proliferation was determined following electrical stimulation at 
developmentally relevant patterns and durations using a BrdU incorporation 
assay (see fig. 11A).  As shown in Figure 11B, SC proliferation was 
significantly reduced following brief (1 hr) stimulation at all frequencies tested 
(0.1, 1, and 10 Hz).  Chronic stimulation at 10 Hz also inhibited SC 
proliferation, but the inhibition was not significantly different from the 1 hour 
timepoint (ANOVA p<0.000, n=66)(Fig. 11B), indicating that only brief 
intervals of axonal firing are required to produce inhibitory effects on SC 
proliferation.   
 Moreover, direct application of ATP (300µM) for 24 hours, inhibited 
SC proliferation in SC-DRG co-cultures (p<0.0009, n=76) (Fig. 11C) and in 
purified SCs grown without axons (p<0.009, n=22).  Importantly, electrical 
stimulation in the presence of apyrase (30U/ml), an enzyme that rapidly 
degrades extracellular ATP (Guthrie et al., 1999), completely inhibited the 







our results implicate ATP as the activity-dependent signal inhibiting SC 








Figure 11.  Inhibition of Schwann cell proliferation by activity-dependent 
release of ATP from DRG neurons 
A.  SC proliferation was measured using a BrdU assay. Proliferation rate was 
calculated as the ratio of BrdU /Hoechst positive SC nuclei/ microscope field.  
All SC nuclei stained with BrdU (green cells, top panel) and Hoechst (blue 
cells, bottom panel) were counted in each microscope field. 
B.   The proliferation rate of SCs was decreased on axons stimulated for 1  and 
48 hrs at 10 Hz.  Brief stimulation at lower frequencies (0.1 and 1 Hz for 1 hr)  
also inhibited SC proliferation. 
C.  The proliferation rate of SCs was decreased on axons stimulated 1 hr at 10 
Hz (10 Hz) compared with SCs on unstimulated axons (0 Hz).   Stimulation in 
the presence of 27U/ml apyrase (10 Hz + apy) prevented the reduction in 
proliferation rate, and direct application of 300 µM ATP for 24 hrs 
significantly inhibited SC proliferation on unstimulated axons.  p < 0.0001, 

















ATP INHIBITS CELL CYCLE PROGRESSION IN SCHWANN CELLS 
 Withdrawal from the cell cycle is a pre-requisite for myelin-related 
differentiation (Asbury, 1967; Morgan et al., 1991). ATP could inhibit 
proliferation by preventing entry into the G1 phase of the cell cycle upon 
stimulation with growth factor or axonal signals.  Alternatively, ATP could 
induce cell cycle arrest in SCs, until the appropriate extracellular signals 
initiate differentiation.  In order to distinguish between these two mechanisms, 
pre-myelinating SCs growing in monoculture were synchronized by serum 
starvation for 24-36 hr, which caused the majority cells to enter the quiescent, 
G0 phase.  Cell cycle re-entry was then initiated by treatment of SCs with 
growth factors (10 ng/mL PDGF) in the presence and absence of ATP. 
Immunocytochemical analysis of G1-phase cyclin expression was measured 
using specific monoclonal antibodies against cyclin D1 and E at different 
timepoints after treatment. 
  Cyclin D is the first cyclin expressed early in G1 (1-3 hrs after addition 
of growth factors), and levels persists throughout the cell cycle.  As shown in 
figure 12A, nuclear cyclin D1 levels were significantly increased 3-9 hours 
after the addition of growth factors both in control and ATP treated compared 
with serum deprived, control cultures (Fig 12A, b,c vs. a).  These data suggest 
that ATP did not prevent SCs from entering G1 phase in response to growth 
factors.  However, nuclear cyclin D levels were significantly reduced in SCs 







controls (see fig. 12B).  That ATP treatment inhibited growth factor- 
stimulation of cyclin D at later timepoints, suggests that ATP arrests SCs in 
mid-late G1 phase of the cell cycle. 
 In contrast to cyclin D, cyclin E is expressed briefly at the G1/S 
transition and levels decline precipitously in early S.   As expected, cyclin E 
levels were low in Schwann cell nuclei in early G1 both in control and ATP-
treated cultures (see fig 12C, a and b), but 18 hours after treatment, cyclin E 
was significantly lower in SCs co-treated with ATP (Fig 12C c and d; Fig 
12D).  Taken together, these data suggest that ATP could be arresting SC 







Figure 12.  ATP treatment arrests Schwann cells in the G1 phase of the 
cell cycle. 
A.  Purified Schwann cells were immunolabeled with a monoclonal antibody 
against cyclin-D1, before (a) and after treatment with growth factors (b) and growth 
factors + 300µM ATP (c).  Nuclear cyclin D levels were significantly increased 18 
hours after the addition of growth factors in the presence and absence of ATP 
compared with serum starved, control cells (b and c vs. a).  
B.  ATP inhibits the growth factor-mediated increase in  cyclin D in the G1 phase of 
the cell cycle.  Cyclin D levels sharply increased in Schwann cell nuclei 6-18 hours 
after addition of growth factors (black curve). ATP treatment inhibited this growth 
factor- stimulated cyclin D increase (red curve) at later timepoints. Cyclin D levels 
were significantly reduced at 12 and 18 hrs after treatment with growth factors + 
ATP compared with controls (GF only) (n= 923 cells). 
C. Schwann cells were fixed and stained with anti-cyclin E every 3 hrs after the 
addition of growth factors +/- ATP.  Cyclin E levels were low in Schwann cell 
nuclei in early G1 (6 hrs after addition of growth factors)  both in control and ATP-
treated cultures. (a and b), but nuclear cyclin E sharply increased in control cultures 
at 18 hours, and this increase was blocked with ATP treatment (c vs. d). 
D. ATP inhibits growth factor-mediated increase in nuclear cyclin E in late G1.  A 
timecourse of nuclear cyclin E expression showed no effect of ATP on the early 
increase in cyclin E between 9-15 hours in control (black curve) and ATP-treated 







significantly lower in SC’s treated with ATP compared with controls (n = 411 
















 Cyclin kinase inhibitors (CKIs) negatively regulate cell cycle 
progression by binding and inactivating specific cyclin-cyclin dependent 
kinase (cdk) complexes (Sherr and Roberts, 1999) (see fig. 10).  CKI levels are 
high in quiescent cells, and during cell cycle arrest, but sharply decline in 
actively cycling cells in response to mitogenic signals. Since ATP appears to 
arrest SCs in the G1 phase, we focused on p21 and p27--two members of the 
CIP/Kip family that negatively regulate G1 progression.  
  To determine whether ATP regulates CDKI expression, SC 
monocultures were treated with PDGF with and without ATP (300µM), and 
p21 and p27 levels were determined immunocytochemically 24 and 48 hours 
later.  Growth factor-stimulated entry into G1 resulted in the predicated down-
regulation of nuclear p21 levels in SCs, but this growth factor-dependent 
decrease in p21 was prevented in the presence of ATP (24h).  After 24 and 48 
hours, nuclear p21 levels were significantly higher in cells treated with ATP 
compared with growth factor-treated controls (see fig 13 A).   In contrast, there 
were no significant differences in p27 levels between growth factor and ATP- 
treated Schwann cells (Fig 13B).   Collectively, our findings suggest that ATP 
may be arresting SC proliferation in late G1, by inhibiting G1 phase cyclins 









Figure 13.  ATP prevents the growth factor-stimulated down-regulation 
of  p21 in Schwann cells.  
A. Growth factor-induced entry into the cell cycle resulted in a down-
regulation of  nuclear p21 levels in control cells (blue), but this decrease in 
p21 was blocked after 24 hours in the presence of ATP (red). After 24 and 
48 hours, nuclear p21 levels were significantly higher in cells treated with 
ATP compared with growth factor-treated controls (p< 0.0001 one-way 
ANOVA, n=19 dishes; * p<0.001 vs. GF controls). 
B.  p27 levels were decreased after exposure to growth factors in the 
presence and absence of ATP, both at  24 and 48 hours compared with  
serum-starved control cultures (-HS).  
Treatment with ATP did not affect this down- regulation, as there were no 
significant differences in p27 levels between growth factor (GF) and ATP- 




















ATP AS A CANDIDATE AXONAL SIGNAL INHIBITING SC 
PROLIFERATION DURING DEVELOPMENT 
  The present study identifies ATP as potent anti-mitotic signal that is 
released from sensory axons in an activity-dependent manner.  ATP released 
from axons under physiological conditions significantly inhibited SC 
proliferation in DRG/SC co-cultures, despite the strong mitogenic influence of 
axons.  Direct application of ATP also inhibited growth-factor induced 
proliferation in SC monocultures. Together these data suggest that extracellular 
ATP is sufficient to over-ride potent mitogenic signals and inhibit SC 
proliferation.  In vivo, the abrupt decline in SC proliferation before the onset of 
myelination corresponds to the onset high frequency firing in DRG axons 
(Fitzgerald, 1987).  We previously reported that ATP is released from cultured 
DRG neurons stimulated to fire action potentials through a TTX-dependent 
mechanism (Stevens and Fields, 2000). While ATP release has not been 
directly demonstrated in vivo, our present findings that apyrase blocked 
activity-dependent inhibition of SC proliferation, further implicate ATP as the 








 Surprisingly little is known about the intracellular mechanisms that 
control growth arrest in Schwann cells.  In general, cell differentiation occurs 
in two stages.  The first involves inhibition of proliferation and arrest in the G1 
phase of the cell cycle (ie, G1-S transition). The second involves changes in 
gene expression that direct a G1-arrested cell to the quiescent phase (i.e. G1-
G0 transition).   Our data suggest that ATP arrests SCs at the G1/S phase of the 
cell cycle through positively regulating the CDKI, p21. Inhibition of cyclin D1 
and E expression in ATP-treated SCs, further imply a late G1 arrest.  
 Importantly, ATP-induced- G1 arrest did not lead to SC differentiation.  
Cell cycle arrest and withdrawal are associated with accumulation of cyclin 
dependent kinase inhibitors (CKIs), such as p21 and p27. Increased expression 
of CKIs in oligodendrocyte progenitors have been shown to induce cell cycle 
arrest, without leading to differentiation (Casaccia-Bonnefil et al., 1999).  
Consequently, independent signal(s) must initiate the second (G1-G0) phase of 
differentiation, which is likely the case in SCs treated with ATP.  By holding 
SCs in this arrested, yet uncommitted stage, ATP could maintain a “plastic” 
pool of Schwann cells until secondary signals induce SC quiescence and 














1. Activity-dependent release of ATP from axons significantly inhibits SC 
proliferation, and arrests SCs in the G1 phase of the cell cycle.  
 
2. Cell cycle arrest occurs in late G1, and the present evidence indicates 










 Schwann cell development is critically dependent on continuous 
signaling from peripheral axons.  While major progress has been made in 
identifying the intracellular signals and transcription factors that regulate 
myelination, the molecular identity of the axonal signal(s) that control SC 
proliferation, differentiation, and myelination remain a mystery. Several in 
vitro studies have established that only post-mitotic Schwann cells (SCs) are 
responsive to myelin-inducing axon signals.  During development SCs stop 
proliferating before differentiating into myelinating or non-myelinating 
phenotypes. The specific aim of these studies was to determine the 
consequences of activity-dependent release of ATP on SC differentiation 
following the arrest of proliferation that results from this axon-Schwann cell 
communication.  
 Growing evidence indicate that all types of glia (microglia, 
oligodendrocytes, astrocytes, and Schwann cells) have membrane receptors for 
extracellular ATP, and that many neurons can release ATP in an activity-
dependent manner (Fields and Stevens, 2000).  Consequently, extracellular 
ATP has been shown to regulate diverse glial functions in the CNS and PNS.  
For example, ATP plays an important role during injury, and in pathological 







hyperexcitability and neurotrauma, where it can trigger astrocyte and 
microglial responses to injury and ischemia (Rathbone et al., 1998), as well as 
induce reactive astrogliosis in vitro and in vivo (Hindley et al., 1994; Bolego et 
al., 1997; Brambilla et al., 1999).  Indeed, activation of purinergic receptors on 
astrocytes has been shown to regulate GFAP expression (Neary et al., 1994a), 
and induce morphological changes in cultured astrocytes (Guenard et al., 
1996), both of which are indicators of astrogliosis.   
  ATP can also trigger microglia to synthesize and release various 
cytokines and chemokines involved in the immune response.  Although the 
majority of studies carried out in astocytes and microglia have been placed in 
the context of neural injury, recent studies suggest that purinergic signaling 
could also regulate astrocyte differentiation during early postnatal development 
(Abe and Saito, 1999; Kukley et al., 2001; Zhu and Kimelberg, 2001). 
 The biological consequences of extrasynaptic ATP release on 
developing Schwann cells are unknown.  During this period (~E16-birth in 
rats), SCs cells are highly plastic and exceptionally sensitive to instructive 
signals from axons.  Embryonic Schwann cells undergo dramatic changes in 
morphology, and gene expression as they cease proliferation and differentiate 
into either mature myelinating or non-myelinating cells (Jessen and Mirsky, 
1999a; Mirsky and Jessen, 1999). The initiation of SC differentiation in vitro 
can be controlled by the addition of ascorbic acid to post mitotic SCs 







marked changes in SC morphology, and gene expression associated with 
myelination (Eldridge et al., 1987; Wood et al., 1990a).  
 The developmental role of impulse activity in regulating glial 
responses, such as myelination, is controversial.  Some studies suggest that 
impulse activity inhibits myelination (Stevens et al., 1998), and others indicate 
that impulse activity promotes myelination (Demerens et al., 1996), or has no 
effect (Shrager and Novakovic, 1995).  Activity-dependent release of ATP 
from pre-myelinated axons could influence maturation of SCs and 





 CELL CULTURE.   
 DRG neurons were obtained from embryonic day 13.5 mice and plated 
at a density of 0.35x106 cells/ml into the side compartments of 
multicompartment chambers. DRG cultures were maintained in medium 
containing 50 ng/ml nerve growth factor (NGF).  Schwann cells were obtained 
from the sciatic nerve of postnatal mice (P2) and cultured and purified using 
the Brockes method (Kleitman et al., 1991) with the following modifications: 
Schwann cells were cultured in medium containing 5% horse serum, and 







fibroblasts.  Purified Schwann cells were maintained in 5% horse serum 
medium, without exogenous growth factors or mitogens until used in 
monoculture or co-cultured into the side compartments (30,000 cells / side) of 
chambers containing 3-week old DRG neurons.  Schwann cells in co- and 
monoculture, were in culture 48-72 hours and incubated overnight in serum-
free medium prior to all experiments.  
 
ELECTRICAL STIMULATION.   
 Neurons were dissociated from the DRG of fetal mice and cultured for 
three weeks in multicompartment chambers equipped for electrical stimulation 
(Fields et al., 1992).  Axons grew into the central compartment by passing 
beneath high resistant barriers separating two side compartments.  This 
allowed electrical stimulation of DRG neurons at various frequencies (1-10 
Hz) and patterns (0.5 sec bursts at 10 Hz every 2 sec) with brief pulses (200 
nsec, biphasic pulses at 5 V) from a custom made multi-channel stimulator. 
The stimulus was monitored continually by an oscilliscope and by light 
emitting diodes in series with stimulating electrodes in each dish. Up to 24 
cultures could be stimulated simultaneously inside the incubator. 
Electrophysiological recording in DRG neurons labeled with DiI show that 
only those neurons with axons traversing the barrier are stimulated to fire 








SC DIFFERENTIATION AND MYELINATION 
 Differentiation was induced in one-week old DRG/SC co-cultures, by 
the addition of ascorbic acid (50ug/mL) in medium containing 5-10% horse 
serum +/- ATP (1-500M).  Morphology changes were observed 3-4 days 
later, and SCs were stained with antibodies against the O4 antigen.  Live 
cultures were incubated with monoclonal O4 antibody (1:10 for 1 hr), and 
antigens were detected using a fluorescein-conjugated goat anti-mouse IgM 
antibody (Jackson Immunoresearch).  The 04 antibody was generously 
provided by Dr. Vittorio Gallo.  Myelin profiles were evident by phase contrast 
microscopy and MBP staining within 10-14 days of the medium shift. Cultures 
received half changes of medium daily with or without 300 µM ATP.  
 
TUNEL ASSAY  
 
 For the apoptosis assay, SCs were fixed with 4% paraformaldehyde 
following treatment.  Cells were stained for TUNEL according to 
manufacturer’s protocol (Roche), and the % of TUNEL-positive cells was 
determined from the ratio of TUNEL/Hoechst-positive cells/microscope field. 
 
IMMUNOCYTOCHEMISTRY 
  Co-cultures were fixed with 2% paraformaldehyde, permeabilized with 
0.1% Triton X-100, and incubated with monoclonal antibodies against myelin 







and 1:50 (Gal-C) for 1 hr at RT. Primary antibodies were detected with 
fluorescein-conjugated goat F(ab’)2 fragment to mouse IgG (Organon Teknika) 
for MBP and Rhodamine-conjugated Fc-specific goat anti-mouse (Jackson 
Immunoresearch) for Gal-C.  Immunocytochemical detection of S-100 (Sigma, 
1:500) was detected with fluorescein-conjugated goat F(ab’)2 fragment to 










ACTIVITY-DEPENDENT ATP RELEASE ARRESTS SC 
DIFFERENTIATION 
    To determine whether ATP can influence SC differentiation,  
SC/DRG co-cultures (1 week in vitro) were treated  with 50 µg/ml ascorbic 
acid + 5% horse serum with and without ATP (300 µM), as described (Stevens 
et al., 1998).  Surprisingly, the normal morphological changes associated with 
maturation of SCs were completely prevented by ATP treatment over a 4 day 
period.  Under control conditions, SC displayed a rounded, flattened 
morphology three to four days after the switch into differentiating media, as 
expected.  In complete contrast, SCs treated with ATP (300µM), remained 
spindle shaped, and failed to closely align with DRG axons (see fig. 14A, a 
vs. c).   
 In addition, expression of the 04 antigen, a marker of SC lineage 
progression, was strongly inhibited in SCs treated with ATP (Fig. 14A b vs. d).  
Chronic treatment of co-cultures with 300 µM ATP resulted in a ~50- fold 
reduction in the number of SCs expression 04 antigen compared to controls, 
while adenosine treatment had no significant effect.  The ATP-dependent 
inhibition of 04 was mimicked by the non-hydrolysable ATP receptor agonist, 
2MeSATP (p< 0.0001, n=15 cultures) (Fig. 14 B), implicating involvement of 







inhibiting 04 expression in SCs.  The proportion of 04-positive SCs was 
measured by computerized optometry, and showed a dose-dependent relation 
to ATP concentration (1-100µM; p<0.001 linear regression against the log of 
ATP concentration; n=8) (Fig.15A a,b).    
  Importantly, the inhibitory effects of ATP on SC differentiation were 
mimicked by neural impulse activity.  The number of 04-positive SCs was 
reduced to 33.5% of controls in cultures stimulated 24-48 hours after co-
culture in a phasic pattern for 7-10 days without ascorbic acid (p<0.03; n=21) 
(see fig. 15B ).  The total number of SCs was not different at this timepoint 
(104 +/- 7.2 versus 108+/- 13 per field), and there was no evidence of 
apoptosis in these co-cultures as determined by cell counts or TUNEL assay 
after 1 hr or 7-days ATP treatment.  In the rat sciatic nerve, 04 expression 
begins prior to differentiation into myelinating or nonmyelinating phenotype 
and continues to be expressed in both phenotypes into adulthood (Mirsky et al., 
1990; Jessen and Mirsky, 1992).   These findings suggest that impulse activity 
could prevent or delay SC differentiation at the pre-myelinating stage of 








Figure 14.  ATP, but not adenosine, arrests maturation and differentiation 
of SCs. 
 A. Chronic treatment of SCs with 300 µM ATP in co-culture with DRG 
neurons for 4 days, prevented the normal development from spindle shaped to 
rounded, flattened morphology (a vs. c). ATP prevented expression of the 04 
antigen (b vs. d), a marker of SC lineage progression from an immature stage, 
just prior to differentiation into premyelinated or promyelinated phenotypes 
B.  ATP (300µM) and the P2 receptor agonist, 2MeSATP (100µM) 
significantly inhibited 04 expression in SCs (18.2+/- 5.7 vs. 0.03+/-0.04, 04 
positive cell/field con vs. ATP, n = 24, p<0.004, t-test).  In contrast, treatment 
of SCs with adenosine (300µM) had no significant effect. 
 
 
Figure 15.  Neural impulse activity inhibits SC differentiation. 
A. The proportion of 04-positive SCs was measured by computerized 
morphometry, and showed a dose-response relation to ATP concentration (1-
100µM; p<0.0001 linear regression against the log of ATP concentration; 
n=8). 
B. The number of 04-positive SCs was also significantly reduced  in co-culture 



























ATP INHIBITS MYELIN GENE EXPRESSION AND FORMATION OF 
MYELIN 
We next looked at several myelin-related proteins to determine whether 
impulse activity could influence myelination by inhibiting the maturation and 
differentiation of SCs.  In the sciatic nerve, the myelin glycolipid 
Galactocerebrocide (Gal C) appears in cells of the myelin pathway before the 
myelin proteins are expressed, and in maturing non-myelinating SCs (Jessen 
1985).  In the present study, the majority of pre-myelinating SCs express Gal-
C in serum/ascorbate-free conditions in DRG/SC co-cultures, which is 
consistent with published reports (Seilheimer et al., 198; (Wood et al., 1990b).  
Within several days of the addition of ascorbic acid, Gal-C was dramatically 
down-regulated in the majority of SCs, and expression was restricted to SCs 
forming myelin sheaths.  Under control conditions, nearly all non-myelinating 
SCs became Gal-C negative at this timepoint, indicating that SCs have 
progressed to the pro-myelinating stage in co-cultures.  When long term co-
cultures were treated with ATP and ascorbic acid, the down-regulation of Gal-
C in SCs was prevented compared to controls, indicating failure to SCs to 
differentiate beyond the immature, pre-myelinating stage (7.4 +/1 0.5 0.5+/- 
0.28 Gal-C positive SCs/field in ATP vs. control, n = 8 cultures, p<0.0001 t-
test) (see fig. 16A).   
       The zinc family transcription factor, krox-20 is expressed in embryonic 







myelinating SCs.  Consistent with these findings, Krox 20 levels are not 
expressed in SCs that differentiate into non-myelinating phenotypes in the 
adult animal (Topilko et al., 1997).  We observed moderate Krox-20 
expression in SCs in short term co-culture with DRG neurons, which is 
consistent with the observation that Krox 20 can be induced in cultured SCs 
24-48 hours after direct contact with axons (Murphy et al., 1996).  Krox-20 
levels were significantly reduced in they majority of SCs in long term 
DRG/SC cocultures treated with ascorbic acid. This ascorbic acid-dependent 
down-regulation of krox -20 was prevented by ATP (89.7% vs. 50% Krox 20 
+ cells, ATP vs. control, p= 0.000,χ2 test, n = 1691 cells) (Fig. 16B).  
Interestingly, the majority of differentiating, 04-positive SCs in control 
cultures did not co-express krox-20 (Fig. 16C), suggesting that in the absence 
of ATP, these SCs may be differentiating into the non-myelinating 
phenotype. 
SCs in the pro-myelinating stage establish a 1:1 association with an 
axon, and initiate ensheathment. In the presence of ATP, SCs remained 
spindle-shaped and were not aligned with axons even after two weeks co-
treatment with ascorbic acid and ATP (Fig.17 a and c).  Moreover, compact 
myelin was not observed in ATP treated cultures, and myelin basic protein 
(MBP), a component of compact myelin, could not be detected by 







morphological evidence suggests that ATP arrests SC maturation prior to 








Figure 16.  ATP prevented the down-regulation of GalC and Krox 20 
expression in differentiating, non-myelinating SCs. 
A.  ATP prevented the ascorbate-induced down-regulation of Gal-C in non-
myelinating SCs compared to controls  (7.4 +/1 0.5 0.5+/- 0.28 Gal-C positive 
SCs/field in ATP vs. control, n = 8 cultures, p<0.0001 t-test). 
B. ATP also prevented the ascorbic acid-dependent down-regulation of krox -
20 (89.7% vs. 50% Krox 20 + cells, ATP vs. control, p  = 0.000, χ2 test, n = 
1691 cells). 
C. Differentiating SCs in co-culture double labeled with antibodies specific 
for 04  (a) and Krox-20 (b).  The majority of differentiating, 04-positive SCs 
(white arrow, a vs. b) in control cultures did not co-express krox-20. 
 
Figure 17.  Chronic ATP treatment prevented the formation of myelin. 
ATP treatment for 10 days prevented the close association of SC with axons (a 
vs. c) and the formation of compact myelin and expression of myelin basic 



























 The maturation of a myelinating SC involves migration, recognition, 
proliferation, ensheathment, and the establishment of an intimate 1:1 
relationship between a SC and a peripheral axon.  The timing of each stage of 
SC development is tightly controlled by multiple extrinsic and axon- derived 
factors to ensure that normal myelination begins around the time of birth 
(Jessen and Mirsky, 1999a).  The present study identifies extracellular ATP as 
an important activity-dependent signal that arrests SC development at a highly 
dynamic stage, prior to the onset of myelination. Through this mechanism, 
neural impulse activity could delay terminal SC differentiation until the 
appropriate axon signal(s) are in place to initiate the myelination program. 
 
ATP MAY CONTROL TIMING OF SC DIFFERENTATION AND 
MYELINATION 
   This study specifically focuses on the effects of ATP on pre-
myelinating SCs, which are bipolar, dividing cells that have not yet committed 
to either the myelinating or nonmyelinating fate.  We provide several lines if 
evidence that extracellular ATP arrests SCs in the pre-myelinating stage of 
development.   
 We found that ATP prevents axon-induced induction of 04 in SCs 







an early differentiation marker.  04 appears as early as ~E16/17 in the rat 
sciatic nerve, and it continues to be expressed in both myelinating and 
nonmyelinating lineages into adulthood (Morgan et al., 1991). Axon contact, 
and elevated cAMP have been shown to induce surface expression of 04 in the 
early pre-myelination period in vitro (Mirsky et al., 1990).  We observed a 
dose –dependent inhibition of 04 by ATP, indicating that physiological levels 
of ATP are sufficient to inhibit 04 expression.  This is further supported by our 
findings that chronic electrical stimulation of DRG/SC co-cultures mimics the 
effects of ATP in inhibiting 04 expression.  In addition, SCs treated with ATP 
were morphologically immature compared to control conditions, SCs remained 
spindle shaped and randomly associated with axons in the presence of ATP, 
even after a week in ascorbate medium.   
 Not surprisingly, the ATP-induced SC arrest at the pre-myelinating 
stage, completely prevented subsequent stages of differentiation, including 
myelination. The onset of spontaneous activity along rat DRG axons in vivo 
precisely corresponds to the appearance of 04 in SCs in the developing rat 
sciatic nerve (Fitzgerald, 1987; Morgan et al., 1991).  Although it is difficult to 
directly compare expression of SC markers in vivo and in vitro, our results 
obtained in DRG/SC co-cultures appear to closely parallel the in vivo 
environment.   
 In contrast to other myelin –related proteins, 04 expression can be 







ATP both prevented expression of 04 in the early pre-myelinating stage, and 
induced a G1-cell cycle arrest, it is tempting to speculate that the two effects 
could be linked.  An ATP-induced G1 growth arrest could prevent 
differentiation to the 04-positive stage.  This could maintain a synchronized 
pool of early premyelinating cells so that induction of 04 and later 
differentiation markers are timed according to the functional requirements of 
axons.  Through this mechanism, ATP could prevent premature differentiation 
into the non-myelinating phenotype, and indirectly promote myelination. 
 That SCs remained morphologically immature even after 2 weeks in 
differentiation medium, suggest that the inhibitory effects of ATP were 
sufficient to override the myelin promoting effects of ascorbic acid, which 
promotes basal lamina formation and stimulate myelination in vitro.  Initiation 
of myelination would thus require that the inhibitory effects of ATP be 
overridden. Several mechanisms could overcome the inhibitory effects of ATP.  
ATP could be chronically released from axons, since neural impulse activity 
continues at higher frequencies in the adult.  In this scenario, ATP may only be 
inhibitory during a narrow window before the appropriate myelin inducing 
signals are in place.  A second possibility is that ATP is only released during a 
narrow window of development, before the onset of myelination.  The 
mechanism(s) regulating activity-dependent ATP release from axons are still 
not well understood, but it remains possible that ATP release is 







ATP via developmental regulation of purinergic receptor expression, or other 
receptor systems that could interact with purinergic receptors to inhibit SC 
development.  Future studies addressing these issues are required before the 
mechanisms underlying ATP-dependent regulation of myelination are 


















1. Chronic ATP treatment of SC/DRG co-cultures prevents morphological 
changes associated with SC differentiation, and potently inhibits 
expression of the early differentiation marker, 04. 
 
2. Chronic electrical stimulation of DRG/SC co-cultures mimic the effects 
of ATP in inhibiting SC differentiation. 
 
 
3. This ATP-induced developmental arrest ultimately prevented the 
expression of myelin basic protein and formation of compact myelin in 















 Extracellular ATP released from pre-myelinated axons was recently 
identified as an important activity-dependent transmitter inhibiting 
proliferation and differentiation of Schwann cells (SCs), the myelinating glia in 
the PNS (Stevens and Fields, 2000).  Activity-dependent ATP release from 
cultured DRG neurons induces calcium transients and gene expression in 
associated SCs (Stevens and Fields, 2000), but the specific types of purinergic 
receptor(s), and intracellular signaling pathways involved in this form of 
neuron-glia communication are not known.   
 There are multiple types of ligand-gated ionotropic (P2X) and G-
protein coupled metabotropic (P2Y) ATP receptors which could interact to 
regulate Schwann cell function in response to extracellular ATP (Ralevic and 
Burnstock, 1998).  In addition, hydrolysis of extracellular ATP by 
ectonucleotidaes can generate adenosine (Zimmermann, 2000), which can 
activate several families of metabotropic adenosine (P1) receptors (Ralevic and 
Burnstock, 1998; Klotz, 2000).  Emerging evidence indicate that CNS glia 
express a complex array of purinergic receptors.  Astrocyes, for example, 
express multiple adenosine and ATP receptor subtypes, often in the same cell 







emerge for cells of the oligodendrocyte lineage  (Stevens et al., 2002a).  It is 
not yet known whether pre-myelinating SCs express functional adenosine 
receptors, or which types of ATP receptors are expressed in developing pre-
myelinating SCs that could be activated in response to extracellular ATP.  
  Simultaneous activation of different purinergic receptors on the same 
cell can activate multiple intracellular signal transduction pathways (Ralevic 
and Burnstock, 1998; Burnstock, 1999).  In addition, purinergic receptors can 
be indirectly linked to other signaling systems, including growth factors, 
neurotransmitters, cytokines, and others (Neary et al., 1996; Rathbone et al., 
1998; Neary et al., 1999a; D'Ambrosi et al., 2001). Consequently, the 
biological outcome of a particular purinergic agonist has been shown to vary 
widely in different cell types.  Activation of ATP receptor  stimulates 
proliferation in many cells, including astrocytes  (Neary et al., 1998; Neary et 
al., 1999b), whereas ATP inhibits Schwann cell proliferation and 
differentiation (Stevens and Fields, 2000).  A more detailed characterization of 
the specific purinergic receptor subtypes and key intracellular signaling 
pathways involved may help explain the disparate functional effects in 
response to purinergic signaling molecules in different cellular systems.  
 We recently reported involvement of the ERK/MAPK pathway in 
activity-dependent axon-SC communication, since inhibition of MEK blocked 
action-potential induced phosphorylation of CREB in SCs (Stevens and Fields, 







been directly demonstrated.  All three members of the MAP family kinases, 
ERK1/2 MAPK, p38MAPK, and JNK-MAPK, can independently and 
cooperatively communicate signals from the membrane to the nucleus to 
regulate gene expression involved in cell cycle and differentiation  (Johnson 
and Lapadat, 2002). The ultimate biological effect of such signaling is 
dependent upon several factors, including the duration and level of kinase 
activation, and the degree of communication between MAPK families and 
other signaling systems, such as purinergic receptors.   Consistent with this 
notion,  new research is demonstrating considerable crosstalk between 
purinergic receptors and MAPK signaling pathways in several cells, including 
Muller glia (Milenkovic et al., 2003)  and astrocytes (Neary et al., 1998; Lenz 
et al., 2001; Milenkovic et al., 2003; Schulte and Fredholm, 2003).   
 New research also indicates an important role for trophic factors in 
modulating purinoreceptor-mediated ERK/MAPK activity.  Adenosine 
receptor agonists can either enhance or inhibit  ERK/MAPK activation, 
depending on the presence of  growth factors in the extracellular environment 
(Arslan et al., 1997; Arslan and Fredholm, 2000). Axonal signals and growth 
factors such as PDGF and neuregulins are critical regulators of SC survival, 
proliferation and development (Stewart et al., 1991; Jessen and Mirsky, 1998; 
Mirsky and Jessen, 1999).  Both growth factors activate the ERK/MAPK 
pathway in cultured SCs (Pleasure et al., 1985; Eccleston et al., 1987; Kim et 







al., 1985; Eccleston et al., 1987; Pleasure et al., 1985;Eccleston et al., 1987), 
either alone or in combination with factors which increase intracellular cAMP 
(Eccleston et al., 1990; Stewart et al., 1991; Kim et al., 1997a).  Since growth 
factors are present at different levels during periods of SC plasticity, i.e. when 
SC are exiting the cell cycle and initiating myelination, it will be important to 
determine whether growth factors influence the functional responses of 
extracellular ATP. 
 The present study demonstrates that electrical stimulation of DRG 
neurons directly activated the ERK/MAPK pathway in associated pre-
myelinating SCs in DRG/SC cocultures, as predicted from our previous work 
(Stevens and Fields, 2000). Surprisingly however, the activity dependent signal 
was identified as adenosine, acting through A2 receptors on premyelinating 
SCs, and not ATP.  In contrast, we show that ATP can inhibit ERK1/2 MAPK 
in SCs by activating P2Y1 receptors and downstream P38 MAPK.  Further, we 
provide evidence that growth factors cooperate with the purinergic signaling 
system to regulate SC proliferation and ERK/MAPK.  Both ATP and 
adenosine inhibited growth factor-dependent proliferation and growth factor 
induction of ERK1/2 in SCs. Collectively, our findings suggest that axonal 
ATP and adenosine released from electrically active axons, activate a complex 
intracellular signaling network, in which ATP and adenosine act together, and 
with growth factors to regulate ERK/MAPK and proliferation in 










CELL CULTURE.   
 DRG neurons were obtained from embryonic day 13.5 mice and plated 
at a density of 0.35x106 cells/ml into the side compartments of 
multicompartment chambers. DRG cultures were maintained in medium 
containing 5% horse serum  supplemented with 50 ng/ml nerve growth factor 
(NGF) according to previously published methods (Fields et al., 1990).  
Schwann cells, obtained from the sciatic nerve of postnatal mice (P2) and 
cultured and purified using the Brockes method (Kleitman et al., 1991) with 
the following modifications: Schwann cells were cultured on to poly-L-Lysine 
coated dishes in medium containing 5% horse serum.  The following day, 
cultures were treated with 10-5 M cytosine arabinoside (AraC) to prevent 
proliferation of non-neuronal cells.  Contaminating fibroblasts were eliminated 
by complement-mediated lysis during passaging with antibody to Thy1.1 one 
week later, and purified Schwann cells were used in experiments within 1 
week.  Purified Schwann cells were maintained in 5% horse serum medium, 
without exogenous growth factors or mitogens until passaged and replated on 
to collagen coated dishes/coverslips, or co-cultured with DRG neurons.  Pre-
myelinated SCs in co- and monoculture, were in culture 48-72 hours and 










ATP, 2-(methylthio)-adenosine diphosphate (2MeSADP), 2-(methylthio)-
adenosine triphosphate (2MeSATP), αβ-methylene adenosine 5’-triphosphate 
(αβ-meATP), 2’-3’-o-(4-benzoyybenzoyl)-adenosine 5’-triphosphate 
(BzATP), uridine-5’ triphosphate (UTP) were purchased from Sigma.  
CGS221680, CCPA, IBMECA, ZM241385, MRS2179 were purchased from 
Tocris Cookson Inc. 
  
 
ELECTRICAL STIMULATION.   
 Neurons were dissociated from the DRG of fetal mice and cultured for 
three weeks in multicompartment chambers equipped for electrical stimulation 
(Fields and Nelson, 1992).  Axons grew into the central compartment by 
passing beneath high resistant barriers separating two side compartments.  This 
allowed electrical stimulation of DRG neurons (10 Hz) from a custom made 
multi-channel stimulator. The stimulus was monitored continually by an 
oscilliscope and by light emitting diodes in series with stimulating electrodes 
in each dish. Up to 24 cultures could be stimulated simultaneously inside the 







show that only those neurons with axons traversing the barrier are stimulated 
to fire action potentials (Li et al., 1996).  
 
CALCIUM IMAGING.  
  Intracellular Ca2+ was monitored in Sacs cultured 48-72 hrs on Poly-L 
Lysine + collagen-coated glass cover slips. Co focal microscopy (Byroad MRC 
1024) with the calcium-sensitive indicator fluo-3 (Molecular Probes, Eugene, 
OR) was used to measure changes in fluorescence intensity (∆F/F0) due to 
calcium transients in Schwann cells in response to purinergic agonists. 
Solutions were applied locally through a multi-barrel pipette using 
electronically controlled valves (Harvard Apparatus).  Measurements were 
carried out at room temperature in a HEPES-buffered balanced salt solution, 
pH 7.2.  A Nikon 40 X , 0.7 n.a. long-working distance lens was used for 
confocal imaging of cells grown on plastic dishes. A 40X Nikon, 1.3n.a. lens 
was used on cells cultured on 0.17nm thick glass coverslips.  Scanning argon 
ion or krypton-argon lasers emitting at 488 nM were used for excitation, and 
imaged with a pin-hole setting of 3.2-4.5mm.  The optical sectioning by 
confocal microscopy allowed us to distinguish calcium responses in Schwann 








IMMUNOCYTOCHEMISTRY.   
 Schwann cell/DRG co-cultures (as well Schwann cells in monoculture) 
were stimulated electrically (10 Hz, 30 min), or pharmacologically and fixed 
immediately with 1-4% paraformaldehyde.  Cells were permeabilized with 
0.2% Triton X-100 and non-specific peroxidases were blocked with 3% 
hydrogen peroxide, followed by a 5% normal goat serum block.  Cultures were 
incubated with antibody against CREB phosphorylated at Ser-133 (1:800, Cell 
Signaling), phosphorylated MAPK (1:500, Cell Signaling), phospho-
p38MAPK (1:250, Cell Signaling) in 3% BSA/PBS overnight at 4 degrees. 
Cultures were then incubated with biotinylated goat anti-rabbit antibody 
(Vector Labs), and localized with the ABC method.  The relative intensity of 
the stain was quantified by using image densitometry on a video microscope 
(Image-1, Universal Imaging).   
 
EXPERIMENTAL DESIGN AND DATA ANALYSIS.   
 The relative intensity of nuclear staining after immunocytochemistry 
was compared by imaging densitometry from multiple culture dishes 
representing controls and all relevant experimental treatments.  Images were 
acquired from at least 15 randomly chosen fields in each culture using a 
Nuvicon video camera and digitized on an 8-bit scale for storage and optical 







Statistical analysis was based on the mean staining intensity of SC cytoplasm 
and/or nucleus in each dish, determined from measurements of all SCs in each 
field (thus, n = number of cultures).  All values were normalized to the mean 
nuclear staining intensity of control cultures in each experiment to allow 
pooling of replicate experiments [arbitrary O.D. units = (nuclear staining 
density/average staining density of control nuclei) X 100) – 100).  This yields a 
scale of 0-55 O.D. units from gray (unstimulated control) to pure black (Fields 
et al., 1997).  The results were presented as mean +- SEM, and statistical 
comparisons were evaluated by ANOVA or two-sample t-test using the 
statistical analysis software Minitab (State College, PA). 
 
RT-PCR 
 RNA was isolated using TRIzol (Invitrogen), from purifed SC 
monocultures, and RT-PCR was performed using 1 µg RNA in a Retroscript 
kit (Ambion), and 5 µl of RT product was amplified using SuperTaq (Ambion) 
in 30 cycles of 94o C (1 min)/60o C (1 min), with 72o C (7 min) after the final 
cycle. Primers for mouse: A2a: 5’ CTC ACG CAG AGT TCC ATC TTC 3’ & 
5’ GAA GCA GTT GAT GAT GTG CAG 3’ (500bp); A2b: 5’ CAG ACC 
CCC ACC AAC TAC TTT 3’& 5’ TGT CAG AGG ACA GCA GCT TTT 3’ 









 SCs 48 hours in culture were serum starved for 18-24 hours before 
treatment with growth factors (10ng/mL PDGF or 250ng/mL B heregulin + 
2µM forskolin) +/- selective purinergic agonists. Cultures were pulsed with 
BrdU (Boehringer Mannheim) for 6 hrs, fixed and stained according to 
manufacturer instructions. Cultures were then counterstained with Hoechst 
nuclear stain (Molecular Probes) at a dilution of 1:2000 for 10 min. 
Proliferation rate was calculated as the ratio of BrdU/Hoechst positive SC 
nuclei/ microscope field.  All SC nuclei stained with BrdU and Hoechst were 
counted in each microscope field.  10-15 randomly chosen fields were sampled 














ACTION POTENTIAL-DEPENDENT ACTIVATION OF ERK1/2 MAPK IS 
NOT MEDIATED BY EXTRACELLULAR ATP 
 Activity-dependent release of extracellular ATP from DRG neurons 
could activate multiple purinergic receptors and intracellular signaling 
pathways to phosphorylate the transcription factor CREB in pre-myelinating 
SCs (see fig. 18).  We previously reported that action-potential dependent- 
CREB phosphorylation was blocked when co-cultures were pre-incubated with 
the MEK1 inhibitor PD098059, suggesting that ATP released from stimulated 
axons may signal through the ERK1/2 MAPK pathway to regulate gene 
expression and SC function during development (Stevens and Fields, 2000). 
 To test this hypothesis, DRG neurons were electrically stimulated (10 
Hz, 30 min), and active ERK1/2 MAPK levels were determined 
immunocytochemically in SCs co-cultured with DRGs in a multicompartment 
chamber equipped with stimulating electrodes (Stevens et al., 1998; Stevens 
and Fields, 2000) (Fig 19A).   Electrical stimulation of DRG neurons 
significantly increased phospho- ERK1/2 MAPK levels in pre-myelinated SCs 
associated with electrically stimulated DRG axons compared with 
unstimulated controls (p<0.0001; n=21, t-test ) (Fig. 19 B).  Only DRG 







compartment are electrically stimulated (Li et al., 1996), therefore imaging 
densitometry was performed in 10-15 random fields along the central barrier 
region of each side compartment (see fig. 19A).  This quantification method 
takes into account the heterogeneity of MAPK staining in our co-cultures, 
since not all SCs are necessarily associated with electrically stimulated axons. 
  Since we previously established that ATP is released from electrically 
stimulated DRG neurons (Stevens and Fields, 2000), we next tested whether 
ATP directly activated ERK/MAPK in SCs.  Surprisingly, ATP and non-
hydrolysable ATP agonist, γSATP failed to activate ERK/MAPK in SCs over a 
wide range of concentrations.  As shown in Figure 19C, agonists selective for 
P2Y ( UTP [P2Y2,4,6])  and P2X subtypes (αΒMeATP [P2X]) were also 
ineffective in activating ERK/MAPK in SCs.  In fact, treatment of SC with the 
potent P2 receptor agonist, 2MeSATP, significantly inhibited ERK1/2 levels in 














Figure 18.  Possible intracellular signaling pathways activated in Schwann 







Figure 19.  Action potential-dependent activation of ERK1/2 MAPK in 
Schwann cells is not mediated by extracellular ATP. 
A. DRG neurons were electrically stimulated (10 Hz, 30 min), and active 
ERK1/2 MAPK levels were determined immunocytochemically in SCs co-
cultured with DRGs in a multicompartment chamber equipped with stimulating 
electrodes.  Electrical stimulation of DRG axons caused phosphorylation of 
ERK/MAPK (10 Hz) compared with unstimulated co-cultures (con).  The 
staining intensity of Schwann cells was compared quantitatively by imaging 
densitometry.  Only DRG neurons that extend axons under the high resistant 
barriers into the central compartment are electrically stimulated, therefore 
imaging densitometry was performed in 10-15 random fields along the central 
barrier region of each side compartment. 
B, Electrical stimulation of DRG neurons significantly increased phospho- 
ERK1/2 MAPK levels in pre-myelinated SCs associated with electrically 
stimulated DRG axons compared with unstimulated controls (p<0.0001; n=21, 
t-test )  
C. ATP and non-hydrolysable ATP agonist, γSATP failed to activate 
ERK/MAPK in SCs over a wide range of concentrations.  Agonists selective 
for P2Y ( UTP [P2Y2,4,6])  and P2X subtypes (αΒMeATP [P2X]) were also 
ineffective in activating ERK/MAPK in SCs.  Treatment of SC with the potent 
P2 receptor agonist, 2MeSATP, significantly inhibited ERK1/2 levels in SCs 
















P2Y1 RECEPTOR ACTIVATION INHIBITS ERK1/2 MAPK IN 
SCHWANN CELLS 
  There are several subtypes of ionotropic (P2X) and metabotropic (P2Y) ATP 
receptors which could mediate ATP-dependent inhibition of ERK1/2 MAPK in 
SCs (see Chapter 1, Fig 3).  Non-myelinating, adult Schwann cells express 
P2Y1 receptors both in situ, while myelinating Schwann cells primarily 
express P2Y2 receptors (Mayer et al., 1998), but the P2 receptor subtypes 
expressed in pre-differentiated SCs are not known.  Time lapse confocal 
microscopy was used to monitor changes in intracellular calcium (Ca2+i) in 
SCs in response to selective ATP (P2) agonists. Our results indicate that pre-
myelinating SCs express several subtypes of functional P2Y and P2X 
receptors, often in the same cell.  Cultured SC responded robustly to P2Y1-
receptor agonists, 2MeSADP and 2MeSATP, as well as the P2Y2/4 agonist, 
UTP (see fig. 20A).  Dose-dependent calcium responses were also observed for 
the P2X agonists, αβMe-ATP (general) and BzATP (P2X7) (Fig. 20B).  Since 
neither  P2Y2/4 (UTP) or P2X (αΒ−MeATP) receptor agonists inhibited 
ERK1/2 MAPK in Schwann cells (Fig. 19C), we postulated that the 
2MeSATP-dependent inhibition of ERK MAPK may be mediated by P2Y1 
receptors. 
 2MeSATP activates P2Y1 receptors with high affinity, but can also 
bind to other P2 receptors when applied at higher doses (Mayer et al., 1998; 







SCs grown in monoculture inhibited ERK1/2 MAPK activity in a dose-
dependent manner.  Lower doses (1µM) of 2MeSATP, significantly inhibited 
ERK1/2 immunostaining, while higher doses (30µM-300µM) were less 
effective (data not shown).   RT-PCR using primers selective for mouse P2Y1 
receptors confirmed that pre-myelinating SCs express the P2Y1 receptor 
mRNA (see fig. 21A).  Consistent with these data, pre-treatment of SC cultures 
with the highly selective P2Y1 receptor antagonist, MRS 2179 (10µM) 
prevented the 2MeSATP-dependent inhibition of ERK1/2 MAPK compared to 
controls (p<0.001, n=24 exps) (Fig. 21B).   Inhibition of ERK was also 
observed when SCS were treated with the selective P2Y1 receptor agonist, 
2MeSADP, and this inhibition was also blocked by MRS 2179 (Fig. 21B).   
Collectively, these data support the hypothesis that P2Y1 receptor activation 







Figure 20.  Pre-myelinating SCs express functional P2Y and P2X ATP 
receptors 
A.  Time lapse confocal microscopy was used to monitor changes in 
intracellular calcium (Ca2+i) in SCs in response to P2Y receptor agonists 
(10µM).  Cultured SC responded robustly to P2Y1-receptor agonists, 
2MeSADP and 2MeSATP, as well as the P2Y2/4 agonist, UTP .   
B.  Dose-dependent calcium responses were also observed for the P2X 
agonists, αβMe-ATP (general) and BzATP (P2X7). 
 
Figure 21   P2Y1 receptor activation inhibits ERK1/2 MAPK in Schwann 
cells. 
A.   RT-PCR using primers selective for mouse P2Y1 receptors confirmed that 
pre-myelinating SCs express mRNA transcripts for the P2Y1 receptor. 
B.  Pre-treatment of SC cultures with the highly selective P2Y1 receptor 
antagonist, MRS 2179 (10 µM) prevented the 2MeSATP-dependent inhibition 
of ERK1/2 MAPK compared to controls (p<0.001, n=24 exps).   Inhibition of 
ERK was also observed when SCs were treated with the selective P2Y1 
receptor agonist, 2MeSADP, and this inhibition was also blocked by MRS 
























ATP NEGATIVELY REGULATES ERK1/2 VIA ACTIVATION OF THE 
P38 MAPK PATHWAY 
 ATP receptor activation could activate multiple downstream kinase 
pathways, including PKA, PKC, CaMK, and p38-MAPK (Zimmermann, 1994; 
Fredholm, 1995; Neary, 1996), to phosphorylate CREB and regulate gene 
expression in SCs (see Fig 18).  In order to determine which of these pathways 
is activated by extracellular ATP, we stimulated SC monocultures with ATP 
(100-300µM for 15- 30 minutes) in the presence of specific inhibitors to each 
of the kinases mentioned above and measured CREB phosphorylation 
immunocytochemically.  Selective inhibition of the p38 MAPK pathway by 
SB203580 (20µM) completely prevented ATP-stimulated CREB 
phosphorylation.   Pre-incubation of PKC inhibitor, GF109203X (1µm) also 
blocked the ATP-dependent CREB phosphorylation in SCs, but inhibition of 
PKA (2µM KT5720), CAMK (30µM KN62) were without effect (p<0.001, 
n=34 exps) (see fig. 22A).  Consistent with the inability of ATP to activate 
ERK/MAPK, the MEK-1 inhibitor, PD098059 failed to block the ATP-
dependent increase in P-CREB, suggesting that activity-dependent release of 
ATP does not signal though the ERK/MAPK to activate CREB as previously 
thought.  Taken together our results suggest that ATP may signal through the 







 The function of p38 MAPK signaling in SCs is largely unexplored.  
While ATP has been shown to activate p38 MAPK in glia involved in 
inflammatory responses, regulation of p38 MAPK by purinergic signaling 
molecules has not been demonstrated in CNS or PNS myelinating glia.  Using 
a phospho-specific antibody, we observed a rapid increase in phospho-p38 
MAPK in SCs following direct application 2MeSATP compared to untreated 
control cultures (Fig. 22Ba).  Maximal increases in phospho-p38 levels were 
observed between 5-10 minutes of 2MeSATP application, and returned to 
control levels after 30 minutes (Fig. 22Bb).   In addition, the P2Y1 receptor 
agonist, 2MeSADP also activated p38 MAPK with similar kinetics (Fig. 
22Bc).  Interestingly, the concentrations of 2MeSATP and 2MeSADP that 
activated p38 MAPK in (1µM) also significantly inhibited ERK/MAPK, 
suggesting a possible link in these two signaling pathways.  
 Indeed, activation of p38 MAPK has been shown to inhibit ERK 1/2 
MAPK in several cell types (Ding and Adrian, 2001; Zhang et al., 2001; Lee et 
al., 2002; Rice et al., 2002), but antagonistic interactions between p38 and 
ERK/MAPK pathways has not been demonstrated in glia.  To determine 
whether the 2MeSATP-mediated inhibition of ERK1/2 MAPK is dependent on 
the p38 MAPK pathway, we stimulated SCs with 2MeSATP in the presence of 
the selective p38 MAPK inhibitor, SB203580.   Pre-incubation of SC cultures 
with SB203580 completely blocked the 2MeSATP-dependent inhibition of 







SB203580 alone was without effect.  Collectively, our results suggest that 
P2Y1 receptor activation by ATP inhibited ERK1/2 MAPK in SCs via a 
p38MAPK-dependent mechanism.  These finding are the first to demonstrate 
possible antagonistic interactions between the p38MAPK and ERK/MAPK in 
glial cells, and identifies a novel signaling pathway by which ATP could 








Figure 22.  P2Y1- receptor mediated activation of p38 MAPK in SCs 
A. SCs were stimulated with 300µM ATP for 15 minutes following pre-
incubation (1 hour) with inhibitors of MEK, CAM kinase, PKA, PKC, and  
p38 MAPK pathways. The ATP-mediated increase in P-CREB was 
significantly blocked by the PKC inhibitor (1µM GF109203X), and 
completely blocked by the p38 MAPK inhibitor (20µM SB203580) 
(p<<0.001 ANOVA; n=34 cultures). Inhibitors of MEK (50µM 
PD98059), PKA ( 2µM KT5720), and CaMK (30µM KN62) had no 
effect.  
B.  (a) Immunocytochemical detection of phosphorylated p38 MAPK indicate 
a rapid increase in phospho-p38 MAPK in SCs following direct application 
2MeSATP compared to untreated control cultures. 
(b)  Maximal increases in phospho-p38 levels were observed between 5-10 
minutes of 2MeSATP application, and returned to control levels after 30 
minutes. 
(c) 2MeSATP, as well as the P2Y1 receptor agonist, 2MeSADP activated p38 
MAPK with similar kinetics.  
C.  Pre-incubation of SC cultures with SB203580 completely blocked the 
2MeSATP-dependent inhibition of ERK1/2 (p<0.001, n=10 exps), and 















PRE-MYELINATING SCHWANN CELLS EXPRESS FUNCTIONAL 
ADENOSINE RECEPTORS 
  If not ATP, than what is the activity-dependent signal activating 
ERK1/2 MAPK Schwann cells in response to axonal firing?  Since 
extracellular ATP is hydrolyzed to adenosine by ectonucleases (Zimmermann 
and Braun, 1996), we considered adenosine as a candidate axonal signal.  
Adenosine was recently identified as an important activity-dependent signal 
regulating oligodendrocyte development (Stevens et al., 2002a), but it is not 
known whether pre-myelinating SCs express functional adenosine receptors.   
 Time lapse confocal calcium imaging was used to determine whether 
pre-myelinating SCs in monoculture responded to adenosine receptor agonists.  
Consistent with published reports, adenosine (300µM) and selective adenosine 
receptor agonists (CCPA [A1], IBMECA [A3], and NECA (A1, A2 and A3]) 
(100 µM) failed to elicit calcium responses in SCs (data not shown).  The A2a 
family of adenosine receptors, signal through cAMP, and are not coupled to 
PLC/IP3, thus A2a receptors would not have been detected in the calcium 
experiments described above.  A2b receptors are also positively coupled to 
cAMP, and can mediate PLC/IPC-dependent Cai 2+ increases in some cells 
types (Yakel et al., 1993; Feoktistov and Biaggioni, 1995).   RT-PCR using 
specific primers for mouse A2a and A2b adenosine receptors detected mRNA 







are the first show that SCs express adenosine receptors in vitro, and implicate 
adenosine as a possible activity-dependent signal between neurons and pre-
myelinating SCs in our system.
 
ACTIVITY-DEPENDENT ACTIVATION OF A2 ADENOSINE RECEPTOR 
ACTIVATES ERK1/2 MAPK IN SCHWANN CELLS 
 To determine whether adenosine activates ERK1/2 MAPK in SCs, we 
applied selective agonists for A1 (CCPA), A2 (CGS21680) and A3 (IBMECA) 
receptors to SC monocultures, and measured ERK1/2 MAPK levels 
immunocytochemically as described previously.  The selective A2 receptor 
agonist, CGS21680 (10µM) significantly increased phospho-ERK1/2 in SCs.  
In contrast, A1 and A3 selective receptor agonists (10µM CPA[A1]; 10µM 
IBMECA [A3]), were without significant effect (p<0.005, n=19 exps)  (Fig. 
23B).  The general adenosine receptor agonist, NECA activated ERK/MAPK 
in SCs in a dose-dependent manner, with maximal activation occurring at 
lower doses (1 µM). Higher concentrations of NECA (300µM) had no 
significant effect on ERK/MAPK (Fig. 23C).  In contrast, a dose –dependent 
increase in ERK activation was observed with the selective A2a receptor 
agonist, CGS21680 (100nM-30µM), with maximal activation occurring at 
higher doses (p<0.003, n=9 exps).  Since NECA can activate both A2A and 
receptors, the A2A-selective antagonist, ZM241385 was used to discriminate 







completely blocked the NECA-stimulated increase in P-ERK1/2 in SCs, and 
there were no significant effects on P-ERK1/2 MAPK levels in SCs following 
treatment with ZM241385 alone (p<0.0001, n=16 exps) (Fig. 23D).  We were 
unable to directly test involvement of A2B receptors, since selective A2B 
agonists and antagonists are not available; however, ZM241385 was used at 
doses that should preclude A2B receptors.  
 A number of soluble signaling molecules could be released from DRG 
axons in an activity-dependent manner to activate ERK/MAPK in SCs.  To 
determine whether adenosine mediates activity-dependent SC-axon 
communication in our system, DRG/SC co-cultures were pre-incubated with 
the A2 receptor antagonist ZM241385, and then stimulated at 10 Hz for 30 
minutes.  As shown in figure 23E, electrical stimulation in the presence of 
ZM231385 significantly inhibited the activity-dependent increase in phospho- 
ERK1/2 immunostaining following electrical stimulation of DRG neurons 
(p<0.004; n=13 exps) (Figure 23E).  Taken together, our results implicate 
extracellular adenosine as the primary activity-dependent signal activating the 








Figure 23.  Activity-dependent release of adenosine activates ERK/MAPK 
in SCs 
A.  mRNA for the cAMP-dependent A2A and A2B receptors was detected by 
RT-PCR using specific adenosine receptor primers in SCs after 2 days in 
monoculture. 
B.  The selective A2 receptor agonist, CGS21680 (10µM) significantly 
increased phospho-ERK1/2 in SCs.  In contrast, A1 and A3 selective receptor 
agonists (10µM CPA[A1]; 10µM IBMECA [A3]), were without significant 
effect (p<0.005, n=19 exps). 
C. The general adenosine receptor agonist, NECA activated ERK/MAPK in 
SCs in a dose-dependent manner, with maximal activation occurring at lower 
doses (1 µM). Higher concentrations of NECA (300µM) had no significant 
effect on ERK/MAPK. 
D.  Pre-incubation with (1µM ) ZM241385 completely blocked the NECA-
stimulated increase in P-ERK1/2 in SCs, and there were no significant effects 
on P-ERK1/2 MAPK levels in SCs following treatment with ZM241385 alone 
(p<0.0001, n=16 exps). 
E. DRG/SC co-cultures were pre-incubated with the A2 receptor antagonist 
ZM241385, and then stimulated at 10 Hz for 30 minutes.  Electrical 
stimulation in the presence of ZM231385 significantly inhibited the activity-
dependent increase in phospho- ERK1/2 immunostaining following electrical 















BOTH ATP AND ADENOSINE INHIBIT GROWTH FACTOR-INDUCED 
SCHWANN CELL PROLIFERATION 
 The ERK/MAPK pathway plays a central role in regulating growth 
factor- dependent proliferation and differentiation of most mammalian cells, 
including developing SCs (Maurel and Salzer, 2000; Meintanis et al., 2001).  
Growth factors, such as PDGF and neuregulins signal through the 
Ras/Raf/MAPK pathway to regulate cell cycle progression (Kim et al., 1997a; 
Maurel and Salzer, 2000; Kim et al., 2001b).  Cross talk between growth 
factors and purinergic receptors regulate ERK/MAPK signaling in astrocytes 
(Munsch et al., 1998; Neary et al., 1999b; Lenz et al., 2000; Panenka et al., 
2001; Neary et al., 2003),  but interactions between growth factors and 
purinergic receptors has not been explored in myelinating glia.  Since growth 
factors are critical regulators of SC growth and development, we were 
interested in determining whether purinergic signaling molecules could 
regulate growth factor-dependent stimulation of SC proliferation. 
  We previously reported that ATP released from axons in response to 
axonal firing significantly inhibits proliferation of cultured SCs (Stevens and 
Fields, 2000), but the specific type(s) of purinergic receptors or signaling 
pathways involved were not identified.  In order to determine which receptors 
mediate inhibition of SC proliferation by ATP, we applied selective ATP and 
adenosine receptor agonists over a wide range of concentrations to SC 







(PDGF, 10 ng/mL) were applied 15 minutes after the addition of purinergic 
agonists in order to stimulate entry in to the cell cycle.   SC proliferation rates 
were then determined 24 hours later using a BrdU incorporation assay after a 6 
hour pulse of BrdU at the end of the 24 hour period.   
    As shown in Figure 24, both ATP and adenosine receptor agonists 
inhibited growth factor-mediated SC proliferation.   2 MeSATP significantly 
inhibited SC proliferation by ~1.5 fold at all concentrations tested (1, 100 and 
300 µM), and this inhibitory effect was mimicked by the P2Y1 receptor 
agonist, 2MeSADP (p<0.004, 18.6+/- 2.1[con] vs. 6.2 +/- 1.0 [ADP]; t-test, 
n=11 exps).   In contrast, agonists selective for P2X receptors (alpha-beta 
methyl ATP and Bz ATP), and P2Y2/4 receptors (UTP) failed to inhibit SC 
proliferation (100 µM) (Figure 24A).    These data implicate involvement of 
P2Y1 receptors in the ATP-dependent inhibition of SC proliferation. 
 Treatment of SCs with adenosine receptor agonists resulted in a more 
pronounced inhibition of proliferation compared to ATP receptor agonists.  
Adenosine at 100 µM inhibited SC proliferation by ~ 10 fold (21.6%+/-
2.8[con] vs. 2%+/- 0.65[Aden];t-test, n=6).  A similar inhibition was observed 
with NECA (100 µM), and with A2a-selective agonist, CGS21680 at 100nM 
(Figure 24B).  We found no evidence for cell death following adenosine or 
ATP receptor agonist treatment at the concentrations which inhibited SC 
proliferation, since the total number of SCs following the 24 hour period did 







indicate that both ATP and adenosine inhibit growth factor-induction of SC 
proliferation through activation of distinct receptor subtypes (P2Y1, and A2), 
despite their opposing effects on ERK/MAPK, a critical regulator of cell 
growth.  These data imply possible crosstalk between purinergic receptors and 
growth factor signaling pathways in controlling SC proliferation, and further 
suggest that growth factors and purinergic receptors could also cooperatively 
regulate ERK/MAPK. 
 
ATP (P2) AND ADENOSINE (A2) RECEPTOR ACTIVATION INHIBITS 
GROWTH FACTOR-DEPENDENT ACTIVATION OF ERK1/2 IN SCS 
 Growth factors such as PDGF, and glial growth factor (GGF) are potent 
SC mitogens via activation of tyrosine kinase receptors and downstream 
Ras/Raf ERK1/2 MAPK pathway  (Kim et al., 1997a; Maurel and Salzer, 
2000; Kim et al., 2001a; Parkinson et al., 2002). Since adenosine receptor 
agonists have recently been shown to have opposing effects of ERK/MAPK in 
the presence and absence growth factors in other PC12 cells (Arslan et al., 
1997; Arslan and Fredholm, 2000),  we next investigated possible cross talk 
between adenosine (A2) and ATP (P2Y) receptors and growth factors 
upstream of ERK/MAPK.  Since the growth factor activation of the 
ERK/MAPK pathway is necessary for G1 progression into the S phase in SCs 







which inhibited growth-factor induction of proliferation may do so by 
interfering with growth-factor induction of the ERK1/2 MAPK cascade in SCs.   
 To determine the effects of ATP and adenosine on growth factor 
activation of ERK/MAPK, SCs were pre-treated with selective P1 and P2 
purinergic agonists 15 minutes prior to application of PDGF, and ERK/MAPK 
was measured in SCS 30 minutes later.  Consistent with our hypothesis, there 
was a dose-dependent correlation between the specific purinoreceptor agonists 
that inhibited both PDGF-dependent activation of ERK and PDGF-stimulation 
of SC proliferation (see fig. 25 A vs. B).   Pre-incubation of SCs with the A2a 
agonist (30nM-1µM) CGS21680 significantly inhibited ERK1/2 MAPK levels 
in a dose –dependent manner, compared to SCs treated with PDGF alone 
(p<0.006;n=9 exps)(Fig. 25B).   NECA (1-300µM) also significantly reduced 
PDGF-induced ERK/MAPK at the same concentrations which inhibited 
PDGF- stimulated SC proliferation (1-300µM) (p<0.0001, n=11 exps).  In 
contrast, adenosine failed to inhibit PDGF-induced ERK MAPK in SCs, 
despite its potent inhibitory effect of SC proliferation (at 100 and 300µM),  
Since adenosine is hydrolyzed into AMP and inosine by ectoenzymes  
(Zimmermann, 2000), it is possible that extracellular adenosine inhibition of 
proliferation is indirect, or that anti-proliferative effects mediated by adenosine 
are independent of the ERK/MAPK pathway.   
 As demonstrated in Fig 25, 2MeSATP and P2Y1-selective agonist, 







when applied at the doses that also inhibited growth factor-dependent 
proliferation(p<0.005, n=10 exps for 2MesATP; p<0.005, n=9 exps for 
2MeSADP).  These findings suggest a mechanism by which increased neural 
impulse activity, through release of purinergic signaling molecules, may over-








Figure 24.  Both ATP and adenosine receptor agonists inhibited growth 
factor-mediated SC proliferation.    
A. 2 MeSATP significantly inhibited SC proliferation ,and this inhibitory 
effect was mimicked by the P2Y1 receptor agonist, 2MeSADP (p<0.004, 
18.6+/- 2.1[con] vs. 6.2 +/- 1.0 [ADP]; t-test, n=11 exps). In contrast, agonists 
selective for P2X receptors (alpha-beta methyl ATP and Bz ATP), and P2Y2/4 
receptors (UTP) failed to inhibit SC proliferation (100 µM). 
B.  Adenosine at 100 µM inhibited SC proliferation by ~ 10 fold.  A similar 
inhibition was observed with NECA (100 µM), and with A2a-selective agonist, 














Figure 25.  Selective ATP and Adenosine receptor agonists prevented 
growth-factor induction of ERK and growth factor stimulation of SC 
proliferation. 
A. Pre-incubation of SCs with the adenosine (100, 300µM), A2a agonist 
(30nM-1µM) CGS21680, and the general adenosine receptor agonist NECA 
(1-300µM), significantly inhibited growth-factor stimulation of SC 
proliferation (red lines).  
2MeSATP and P2Y1-selective agonist, 2MeSADP (blue lines) also inhibited 
growth factor-dependent proliferation 
B. Pre-incubation of SCs with the A2a agonist (30nM-1µM) CGS21680, and 
the general adenosine receptor agonist NECA (1-300µM) , significantly 
inhibited growth factor activation of ERK1/2 MAPK levels in a dose –
dependent manner.  In contrast, adenosine failed to inhibit PDGF-induced 
ERK MAPK in SCs despite its potent inhibitory effect of SC proliferation (at 
100 and 300µM) as shown above in A.   
2MeSATP and P2Y1-selective agonist, 2MeSADP (blue lines) significantly 
inhibited PDGF-dependent activation of ERK/MAPK when applied at the 
















 The present work identifies adenosine as novel axonal signal mediating 
activity-dependent communication between neurons and pre-myelinating 
Schwann cells.  Using a combination of pharmacological and molecular 
approaches, we found that cultured mouse SCs express functional adenosine 
receptors, in addition to multiple subtypes of ATP receptors (P2X and P2Y) -- 
a far more complex array of purinergic receptors than previously thought.  
While both adenosine and ATP receptors are activated in SCs in response to 
neural impulse activity, these two families of purinergic receptors can have 
opposing effects on ERK/MAPK activity.  Adenosine activated ERK/MAPK 
through stimulation of A2 adenosine receptors. In contrast, extracellular ATP 
inhibited ERK/MAPK activity, through activation of P2Y1-receptors coupled 
to the p38MAPK pathway. These findings are summarized in Figure 26.  We 
further demonstrated that the presence of growth factors in the extracellular 
environment can alter the effects of ATP and adenosine on ERK/MAPK.  











Figure 26.  Antagonistic roles of ATP and adenosine on ERK/MAPK 







PRE-MYELINATING SCHWANN CELLS EXPRESS FUNCTIONAL 
ADENOSINE AND ATP RECEPTORS 
 A major finding in this study is that pre-myelinating SCs express 
functional adenosine receptors.  Recent reports have demonstrated expression 
of all four subtypes of adenosine receptors in cultured and acutely isolated 
oligodendrocyte progenitor cells (Stevens et al., 2002), and astrocyes  (Pilitsis 
and Kimelberg, 1998), however adenosine receptors in PNS glia have not been 
previously characterized.  Calcium transients have been observed in 
perisynaptic Schwann cells surrounding the neuromuscular junction, but these 
specialized PNS glia are structurally and functionally distinct from SCs 
associated with extrasynaptic myelinated and non-myelinated axons.  In fact, 
several reports have demonstrated that adenosine failed to elicit calcium 
responses in SCs, both in vitro and in situ (Lyons et al., 1994; Mayer et al., 
1997; Mayer et al., 1998). Using RT-PCR and selective adenosine receptor 
agonists and antagonists, we identified functional A2-type adenosine receptor 
subtypes in cultured, pre-myelinated SCs.  Since this class adenosine receptors 
are positively coupled to cAMP, and not Cai 2+ , it is possible that these 
receptor subtypes were present in studies in which adenosine failed to elicit 
calcium responses in SCs.   
 We also identified both ionotropic (P2X), and distinct subtypes of 
metabotropic ATP (P2Y), in pre-myelinating SCs.  Our previous work 







ATP-evoked calcium transients were observed in SC in the absence of 
extracellular calcium.  In addition, activity and ATP-dependent gene 
expression in SCs was blocked by the general P2 receptor antagonist, suramin 
(Stevens and Fields, 2000), but these findings did not preclude expression of 
P2X receptors.  This study found that while pre-myelinating SCs expressed 
P2X receptors, they do not appear to regulate ERK/MAPK or proliferation in 
SCs.   In addition, pre-myelinating SCs co-express of P2Y1 and P2Y2 (and 
possibly P2Y4) receptors, but here we have shown that inhibition of 
ERK/MAPK and SC proliferation was selectively mediated by P2Y1 receptors.  
Further molecular and functional characterization of the specific subtypes of 
P2X and Y receptors expressed in pre-myelinated and differentiated SCs may 
identify other classes of P2 receptors which could further regulate SC gene 
expression and function. 
        
ADENOSINE AND ATP CAN HAVE OPPOSING EFFECTS ON THE 
ERK/MAPK PATHWAY IN SCHWANN CELLS 
 Activation of ERK/MAPK underlies the mitogenic effects of many 
growth factors, and it is now widely accepted that regulation of ERK/ MAPK 
is far more complex than a linear pathway from membrane receptor to kinase.  
ERK/MAPK may represent a critical point of convergence from multiple 
intracellular signaling cascades coupled to diverse membrane receptors. 







information to the nucleus to regulate genes involved in cell cycle and 
differentiation (Bhalla and Iyengar, 2001; Bhalla et al., 2002).  Consequently, 
the degree and kinetics of ERK activation appear to be far more important in 
determining the biological outcome to an extracellular signal than simply 
activation itself.  This hypothesis may explain why the same signal can have 
opposing effects in different cell types, or why the effects of a particular signal 
on ERK/MAPK varies in the same cell, depending on the biological context.  
Our results suggest that the net effect on ERK/MAPK in Schwann cells is 
likely dependent on several factors including, purinergic receptors expression, 
extracellular concentration and rate of ATP hydrolysis, and importantly, the 
degree of cross talk among purinergic receptor subtypes and other signaling 
systems.   
  Our findings suggest that activation of specific purinergic receptors 
can differentially regulate ERK/MAPK in SCs. This is consistent with a recent 
study by Lenz et al (2000), which showed distinct P2Y subtypes can recruit 
different MEK activators in cultured astrocytes (Lenz et al., 2000; Lenz et al., 
2001).  Our results indicate that different types of ATP and adenosine receptors 
can have can have opposing effects on ERK/MAPK in SCs.  Acute application 
of ATP, and its non-hydrolysable analog, γSATP, had no effect on 
ERK/MAPK activity in SC monocultures.   In contrast, activation of A2 
adenosine receptors significantly increased ERK/MAPK levels, where as P2Y1 







are positively coupled to adenylate cyclase via Gs proteins, and increase 
intracellular cAMP levels (Seidel et al., 1999; Schulte and Fredholm, 2000; 
Klinger et al., 2002; Schulte and Fredholm, 2003).  In SCs, A2A may activate 
ERK/MAPK via the cAMP-dependent PKA pathway, as has been 
demonstrated in several cell types levels (Seidel et al., 1999; Schulte and 
Fredholm, 2000; Klinger et al., 2002; Schulte and Fredholm, 2003).  In 
contrast, ATP/P2Y receptors appear to signal through the p38MAPK pathway, 
and not ERK/MAPK.  Our findings that ATP- mediated phosphorylation of 
CREB is dependent on both PKC and p38MAPK, and independent of PKA 
and MEK/ERK is consistent with this notion.  Although this study did not 
extensively characterize the upstream elements involved these two signaling 
cascades, our observed antagonistic effects of ATP and adenosine on 
ERK/MAPK indicate that different families/subtypes of purinergic receptor 
expressed in pre-myelinating SCs may cooperatively modulate ERK/MAPK 
activity in SCs. 
 Importantly, this study provided evidence that action-potential 
dependent release of ATP from sensory axons activates ERK/MAPK in 
associated SCs.  While pharmacological stimulation of specific receptor 
subtypes allowed us to characterize the receptors that regulate ERK/MAPK in 
SCs, it is unlikely that a single receptor subtype would be activated under 
physiological conditions, especially given our findings that SCs express 







closely models the in vivo environment by allowing pre-myelinating SCs to 
naturally associate with axons--which provide a host of survival and growth 
signals absent in SC monocultures. In addition, our system enabled electrical 
stimulation of axons at frequencies representative of developing axons before 
the onset of myelination (Fitzgerald, 1987).   
 Several lines of evidence implicate adenosine as the primary activity-
dependent signal mediating ERK activation in SCs.  Activity-dependent 
activation of ERK/MAPK was blocked by the selective A2 receptor 
antagonists ZM241385.  Consistent with these data, the selective A2 receptor 
agonist, CGS 21680 activated ERK in a dose dependent manner, as did NECA 
at nM concentrations.  That ATP failed to activate ERK under the conditions 
of our study ERK/MAPK, further excluded involvement of ATP/P2 receptors 
in activity-dependent activation of ERK/MAPK. 
 We previously reported that ATP is released extrasynaptically from 
DRG neurons in an activity-dependent manner (Stevens and Fields, 2000).   
Extracellular ATP is hydrolyzed to ADP, AMP and ultimately to adenosine, 
which can modulate cell function via its own receptors.  The rate and degree of 
ATP hydrolysis, is tightly regulated by several complex families of 
ectonucleases, which act together to terminate nucleotide signaling at their 
respective receptors (Zimmermann et al., 1998).   Our findings suggest that 
ATP is sufficiently hydrolyzed to adenosine during the 30 minute stimulation 







Ectonuceotidases may be absent in SCs grown without axons, since acute 
stimulation (30 min) of ATP to SCs monocultures failed to activate ERK, 
where as activity-dependent generation of ATP activated ERK in SCs in 
DRG/SC co-cultures.  Consistent with this notion, agents that increase 
intracellular cAMP levels (thus mimic axonal signals)  have been recently 
shown to significantly up-regulate an ATPase in cultured Schwann cells 
(Bermingham et al., 2001).  We have not ruled out the alternative possibility 
that adenosine is directly released from DRG neurons in an activity –dependent 
manner.  Future studies will be necessary to determine whether 
ectonucleotidases are involved in regulating activity-dependent axon-SC 
communication.  
   
ATP ACTIVATES P38 MAPK IN SCHWANN CELLS AND INHIBITS 
ERK/MAPK 
 Our results are the first to demonstrate activation of p38 MAPK by 
purinoreceptors in myelinating glia.  In contrast to ERK and JNK family-
MAPKs, the role of p38 MAPK in the nervous system is poorly understood.  
As its name implies, the stress activated protein kinase (SAPK), p38 MAPK is 
preferentially activated by environmental stress such as UV radiation, heat and 
osmotic shock, and by inflammatory signals such as TNF, IL-1, and TGF-β 
(Koistinaho and Koistinaho, 2002).  Activation of the p38 MAPK pathway 







et al., 1997; Ridley et al., 1997; Ridley et al., 1998; Chae et al., 2001).  In the 
CNS, p38 MAPK is activated in microglia (Bhat et al., 1998; Pocock and 
Liddle, 2001; Shigemoto-Mogami et al., 2001) and astrocytes (Bhat et al., 
1998; Panenka et al., 2001; Schinelli et al., 2001) in response to hypoxia, and 
injury-related signals including ATP, which is consistent with the recognized 
role of these glial cells in acute brain injury and neurodegenerative diseases.  
Much less is known about the function of p38MAPK in myelinating glia in the 
central and peripheral nervous system.   
 Here we presented the first evidence of ATP-dependent activation of 
p38 MAPK in Schwann cells.  Direct activation of ATP/P2Y receptors at low 
concentrations, induced rapid and transient activation p38 MAPK in pre-
myelinated SCs.  Both 2MeSADP and 2Me SATP activated p38MAPK at the 
same concentrations and kinetics, suggesting involvement of P2Y1 receptors.  
In addition, ATP-dependent CREB phosphorylation was blocked by p38 
MAPK inhibitor, SB203580, further implicating involvement of this MAPK.  
Although the specific regulators of  p38 MAPK cascade are poorly defined, 
CREB has been reported as a downstream target of p38 MAPK in a number of 
cell types (Xing et al., 1998; Hansen et al., 1999; Pugazhenthi et al., 1999; 
Schinelli et al., 2001), and PKC has been reported as an upstream activator of 
p38 MAPK (Loubani and Galinanes, 2002).  Here we showed that selective 
inhibition of PKC by GF109203X and p38 MAPK by SB203580 both 







upstream of p38MAPK in SCs has not been determined.  PKC and p38 MAPK 
could alternately activate CREB through parallel pathways, as has been 
reported (Fiebich et al., 2001).   
 Interestingly, our observation that P2Y1-receptor mediated inhibition 
of ERK/MAPK in SCs was dependent on p38 MAPK is in line with several 
recent reports demonstrating negative regulation of the ERK1/2 pathway by 
p38 MAPK (Singh et al.,1999; Hall et al., 2002; Lee et al., 2002; Ahuirre-
Ghiso et al., 2001; Ding et al., 2001). p38 MAPK has been shown to inhibit 
ERK by two different mechanisms: via activation of protein phosphatases, 
which inhibit MEK/ERK activation (Westernmarck et al. 2001), and via direct 
physical interactions between p38α and ERK1/2, in which p38 appears to 
sequester ERK1/2 and sterically block their phosphorylation by MEK1 (Zhang 
et al 2000).  
 In addition to regulating stress-related functions, the p38 MAPK 
pathway also plays a critical role in regulating cell cycle, growth and 
differentiation (Bogre et al., 2000; Ono and Han, 2000).  Activation of 
p38MAPK was recently shown to induce cell cycle arrest via inhibition of the 
Raf/ERK pathway during muscle differentiation (Lee et al., 2002).  p38 MAPK 
was also shown to negatively regulate PDGF-mediated proliferation of 
myofibroblasts by directly interacting with ERK1/2 and suppressing its 
phosphorylation (Rice et al., 2002).  In addition, there is growing evidence that 







p38 MAPK has been shown to negatively regulate the transcription if Cyclin 
D1, and induce cyclin-dependent kinase inhibitors (CDKIs) (Page and 
Hershenson, 2001; Lavoie et al., 1996).   
 The mechanisms by which p38 negatively regulates ERK1/2 in SCs 
remains to be determined, but it is tempting to speculate that ATP-dependent 
inhibition of ERK by p38 MAPK via one of above mechanisms could underlie 
ATP/P2Y receptor mediated inhibition of SC proliferation. Unpublished 
observations from our laboratory indicate that ATP receptor activation in SCs 
induced G1 arrest, inhibited cyclin D1, and prevented the down-regulation of 
the CDKI, p21 in the presence of growth factors (see Chapter 3; Figs 12,13).  
Future studies using dominant negative approaches may be useful in directly 
testing this hypothesis, since pharmacological perturbation of p38 and ERK 
kinases can inhibit SC proliferation, and interfere with proliferation 
experiments. 
 
CROSS TALK BETWEEN PURINERGIC AND GROWTH FACTOR 
RECEPTORS IN REGULATION OF ERK/ MAPK AND PROLIFERATION 
IN SCS 
 Schwann cell proliferation is regulated by direct interactions with axons 
during embryonic and early postnatal development (Salzer and Bunge, 1980; 
Wood and Bunge, 1975), or in response to peripheral nerve injury (Bradley 







neuregulins are potent SC mitogens to cultured SCs when applied in 
combination with agents that increase cAMP (Stewart et al., 1991).  It has been 
proposed that increased levels of intracellular cAMP, induced by unknown 
axonal factors, act as a primary signal that synergizes with growth factors to 
activate ERK/MAPK, and stimulate cell cycle progression (Kim et al., 1997a; 
Kim et al., 2001a; Stevens and Fields, 2002). At the same time, cAMP 
elevation in post-mitotic SCs promotes differentiation and myelination (Sobue 
and Pleasure, 1984; Sobue et al., 1986; Morgan et al., 1991), indicating that 
cAMP can exert opposing functional effects (proliferation vs. differentiation) 
in the same cell type under different biological contexts.   
 Recent studies in SCs (Kim et al. 1997), and a variety of other cell 
types  indicate that cAMP/PKA plays a crucial and generalized role in 
transducing growth factor signals to the nucleus (Stork and Schmitt, 2002).  In 
Schwann cells, the ERK/MAPK cascade represents a point of cross-talk 
between growth factors and cAMP signaling pathways, whereby cAMP can 
either enhance or inhibit growth-factor mediated ERK signaling (and cell cycle 
progression) by regulating kinases upstream of ERK, such as Ras/Raf-1 or 
Rap-1/BRaf (Kim et al., 1997a; Kim et al., 1997b; Kim et al., 2001a).  For 
example, pretreatment of SCs with forskolin, significantly reduced neuregulin-
induced ERK/MAPK in SCs (Kim et al., 1997a).  In addition, the intracellular 
concentration of cAMP is also important in determining the level and duration 







demonstrated that low concentration of cAMP (0.1mM) activated S6 kinase in 
SCs (an immediate target of activated ERK), resulting in transient, and high 
levels of ERK1/2--conditions that stimulate SCs proliferation.  In contrast, 
high concentrations of cAMP (>1mM), induced a smaller activation of S6 
kinase activation, and smaller but prolonged ERK/MAPK--conditions that 
induce SC differentiation (Sobue et al., 1986) (Mutoh et al., 1998).  A similar 
paradigm has been shown in PC12 cells (Marshall, 1995).  Thus, the ability of 
cAMP to both promote proliferation and differentiation in SCs appear 
dependent on relative concentrations of cAMP and the kinetics of ERK1/2 
activation, rather that simply activation or inhibition. 
 The identity of the axon signal(s) which increase cAMP to 
differentially regulate SC proliferation and differentiation during development 
are not known, but our results suggest adenosine as a possible candidate.  Our 
in vitro findings suggest that adenosine may be released from electrically 
active axons (either directly or via breakdown of ATP) during the time when 
SCs are exiting from the cell cycle, and differentiating into myelinating or 
nonmyelinating phenotypes.  G-protein coupled -A2 adenosine receptors are 
positively coupled to adenosine and increase intracellular cAMP, and cAMP-
dependent activation of ERK1/2 by Gs-coupled A2a and b receptors have been 
shown in several cell types (Schulte and Fredholm, 2003).   
 Adenosine can exert an ERK1/2- dependent mitogenic effects in some 







phosphorylation.  Arslan and Fredholm (2000) reported that acute treatment 
with adenosine receptor agonists alone activated ERK/MAPK in PC12 cells, 
even at low doses.  However, when adenosine was acutely applied to cells in 
the presence of NGF, adenosine inhibited NGF-induced ERK.  This was 
attributed to an inhibition of Raf1in PC12 cells  by high levels of cAMP, 
which consequently interfered with NGF-mediated effects (Arslan and 
Fredholm, 2000).  These results are strikingly similar to our present findings in 
SCs. While acute activation of A2 adenosine receptors activated ERK/MAPK 
in SCs, adenosine blocked the PDGF-induced activation ERK, and 
proliferation in the presence of growth factors.  Interestingly, A2A receptor 
expression is dramatically down regulated in differentiated cells, compared to 
pre-differentiated PC12 cells, which highly express A2A receptors (Arslan et 
al., 1997).  Therefore adenosine can exert different functional effects in pre-
differentiated vs. post differentiated PC12 cells, in response to the same 
purinergic signal.  This is in line with the longstanding observations that 
cAMP can opposing effects on ERK and SC function in differentiated vs. pre-
differentiated stage in development.   
 The onset of high frequency neural impulse activity, and possible ATP 
release from sensory axons, corresponds to a critical period in development, 
when SCs stop proliferating, and differentiate into mature myelinating  or non-
myelinating phenotypes (Fitzgerald, 1987; Fields and Stevens, 2000).  Our 







with trophic factors to balance MAPK signaling in SCs to meet functional 


























1.  Electrical stimulation of DRG neurons directly activates the ERK/MAPK 
pathway in associated pre-myelinating SCs in DRG/SC co-cultures.  
 
2.   The activity-dependent signal was identified as adenosine, acting through 
A2 receptors on premyelinating SCs, and not ATP.   
 
3.   ATP can inhibit ERK1/2 MAPK in SCs by activating P2Y1 receptors and 
downstream P38 MAPK. 
 
4.   Both ATP and adenosine inhibited growth factor-dependent proliferation 












 Electrical activity plays a crucial role in modifying developing neural 
circuits in the perinatal period.  Neural impulse activity regulates neuronal 
gene expression, neurite outgrowth, neuronal morphology, and the stabilization 
of synaptic connections (Buonanno and Fields, 1999; Penn and Shatz, 1999; 
Fields et al., 2001), yet much less is known about the role of neural activity in 
controlling glial development.  The present findings are the first to demonstrate 
activity-dependent communication between axons and pre-myelinating 
Schwann cells, and identify extracellular ATP as a potent and dynamic axonal 
signal regulating Schwann cell gene expression, proliferation, differentiation, 
and myelination in response to axonal firing.  
 Here these data will be put into a larger developmental context, and the 
implications of these findings will be further discussed with respect to the 
specific aims outlined in the introduction. Additionally, the strengths and 
limitations of the methodologies used in these studies will be highlighted, with 
particular emphasis on the requirements necessary for implicating ATP as an 
axonal signal regulating Schwann cell development in vivo.  Future directions 








ACTIVITY-DEPENDENT COMMUNICATION BETWEEN AXONS AND 
DEVELOPING SCHWANN CELLS 
 The first fundamental question that was addressed in this research was 
whether immature, pre-myelinating Schwann cells could respond to neural 
impulse activity. While there is evidence to support activity-dependent neuron-
Schwann cell communication at the synapse, as well as the paranode of mature 
myelinated axons, the present findings are the first to identify this form of 
communication between axons and developing, pre-myelinated SCs.   A 
DRG/SC co-culture system equipped with stimulating electrodes was 
developed to electrically stimulate DRG neurons, and study the ensuing effects 
in pre-myelinating SCs.  Confocal calcium imaging experiments revealed that 
electrical stimulation of DRG neurons elicited robust calcium responses in 
associated SCs.  These calcium transients were observed several seconds up to 
minutes after the onset of neural impulse activity, which strongly suggested 
involvement of a soluble axonal signal.  As will be discussed below, the 
activity-dependent signal between axons and pre-myelinating SCs was 
identified as extracellular ATP.  It was further found that activity-dependent 
release of ATP activated multiple intracellular signaling pathways in SCs, 
phosphorylated CREB, and increased levels of the transcription factors, c-fos 
and krox-24 in SCs.  Together these findings address each of the questions 







will be further discussed and contrasted with related experiments in the adult 
nervous system. 
  This research identified ATP as the activity-dependent signal 
mediating calcium signaling and gene expression in pre-myelinating SCs.   
Although SCs are responsive to multiple neuroactive signals that could be 
released from DRG axons in an activity-dependent manner, this research 
provides several lines of evidence that ATP is the primary activity-dependent 
axonal signal in our system.  First, pre-myelinating SCs express functional 
ATP receptors.  Using a combination of imaging, pharmacological and 
molecular approaches, several types of ATP receptors were identified in pre-
myelinating SCs (P2Y and P2X).  Second, selective ATP receptor agonists 
mimicked the electrically induced calcium responses in SCs.  Third, activity-
dependent calcium transients were completely blocked in Schwann cells in the 
presence of apyrase, an enzyme that rapidly degrades extracellular ATP.  
Activity-dependent increases in PCREB, c-fos and krox-24 were also 
prevented when cultures were stimulated in the presence of apyrase, and/or the 
general P2 receptor antagonist, suramin.   
 Fourth, extracellular ATP was released from DRG axons in response to 
sodium-dependent action potential activity.  Medium collected from pure DRG 
cultures stimulated at 10 Hz showed a highly significant increase in ATP 
compared with unstimulated controls. Electrically induced ATP release 







stimulation), and was completely prevented when sodium-dependent action 
potentials were blocked with TTX.   Furthermore, increased levels of ATP 
were observed in the central axonal compartment of our chamber preparation 
that lacked DRG cell bodies, suggesting that ATP was released from 
electrically active axons.  The mechanisms of extrasynaptic ATP release are 
currently under active investigation.  Together these findings strongly 
implicate extracellular ATP as the activity-dependent signal regulating calcium 
signaling and gene expression in pre-myelinating SCs. 
 While there are general limitations associated with an in vitro system, 
our co-culture model has several unique advantages for the study of activity-
dependent communication between neurons and developing SCs.  First, only 
neurons with axons traversing the central barriers are stimulated to fire action 
potentials, thus SCs are not directly stimulated. Second, DRG neurons are not 
spontaneously active, nor do they form synapses in vitro (Li et al., 1996). 
These features allowed electrical stimulation of DRG neurons at 
developmentally relevant frequencies (1, 3, 10 Hz), and the study of SC 
responses in an extrasynaptic environment.  Finally, the developmental stage 
of SCs cultured from rodent sciatic can be tightly controlled and characterized 
at the morphological and biochemical levels. Since SC lineage progression in 
DRG/SC co-cultures closely parallels that of the intact sciatic nerve, SCs were 
co-cultured at the immature, pre-myelinated stage, in order to study the effects 







onset of differentiation and myelination.  Using a combination of imaging, 
biochemical, and pharmacological approaches, this model system enabled us to 
identify ATP as an activity-dependent signal between neurons and pre-
myelinating SCs.  These studies lay the foundation for designing specific 
experiments to address similar questions in vivo. As will be discussed below, 
several in situ studies provide evidence for activity-dependent communication 
between neurons and Schwann cells in the adult animal. 
  Purinergic signaling molecules have also been shown to mediate 
activity-dependent neuron-SC communication at the adult neuromuscular 
synapse (Castonguay and Robitaille, 2001). Terminal Schwann cells 
surrounding synaptic terminals at the neuromuscular synapse express 
functional ATP (P2Y and X), and synaptic release of ATP has been shown to 
induce calcium transients in terminal SCs at the frog neuromuscular junction 
(NMJ) (Robitaille, 1995).  Although certain parallels exist between synaptic 
and the extrasynaptic neuron-SC signaling presented here, there are several 
significant difference between studies at the adult synapse, and the present 
research.   
 First, terminal Schwann cells are specialized cells, which more closely 
resemble perisynaptic CNS astrocytes that myelinating or cultured SCs. Aside 
for the obvious functional differences, terminal Schwann cell differ structurally 
and biochemically from SCs associated with extrasynaptic regions of axons 







Although they express several myelin-related proteins, (such as P0, MBP, and 
GalC), terminal SCs do not form myelin.  
 A second major distinction is that ATP does not appear to mediate 
activity dependent SC-axon communication at the frog NMJ (Rochon et al., 
2001), as it has been reported in the frog (Robitaille, 1998).  Curiously, both 
rodent and frog terminal SCs express functional ATP receptors, but P2 
receptor antagonists failed to reduce activity-dependent calcium transients in 
rodent terminal SCs, suggesting functional differences in purinergic signaling 
exist in these two species.  This discrepancy may reflect evolutionary 
modifications in the way that terminal SCs respond to synaptic activity (Auld 
and Robitaille, 2003). Alternatively, these difference could be due to technical 
issues such as species –specific selectivity of purinergic antagonists used in 
these studies (Fredholm, 1995) . 
 In addition, ATP mediated activity-dependent gene expression has not 
been demonstrated in terminal SCs in either the rodent or frog NMJ.  Although 
synaptic activity has been shown to down-regulate GFAP expression in 
terminal SCs at the frog NMJ, the activity dependent neuron-SC signal was 
identified as acetylcholine (acting on muscarinic AchRs), and not ATP or 
adenosine (Georgiou et al., 1994).   In addition, ATP and/or activity-dependent 
regulation of SC proliferation or differentiation has not been adequately 







 Activity-dependent axon-SC signaling has also been studied to some 
extent in myelinating SCs at the amphibian Node of Ranvier  (Lev-Ram and 
Ellisman, 1995), however the involvement of purinergic signaling molecules at 
the adult node  in unclear.  Paranodal SCs responded to high frequency axonal 
stimulation in situ, however the activity-dependent signal(s) were not 
characterized. It was hypothesized that potassium efflux from axons following 
activity induced depolarization on the paranodal loops, resulting in calcium 
influx from external sources (possibly voltage-gated calcium channels).  It 
remains possible that ATP may have contributed to the activity-dependent 
calcium fluxes in myelinating SCs, but this was not directly investigated.  In 
fact, in situ studies of adult, rodent peripheral nerves demonstrated that 
paranodal SCs express functional metabotropic (P2Y2) and ionotropic (P2X7) 
ATP receptors (Mayer et al., 1997; Grafe et al., 1999), suggesting that adult 
myelinating SCs are indeed responsive to extracellular ATP.       
 In contrast, electrical stimulation of adult frog NMJ failed to elicit 
calcium transients in the proximal myelinated SCs in another study (Reist and 
Smith, 1992), but calcium transients were observed in the terminal SCs.   
Electrical stimulation of unmyelinated adult rat vagus nerve also failed to elicit 
calcium responses in associated SCs.  As discussed briefly in chapter 2, these 
discrepancies may reflect different stimulation paradigms used in each study.  
Given that adult myelinating and non-myelinating SCs can respond to ATP 







electrical stimulation (Reist and Smith, 1992; Mayer et al., 1998; Wachtler et 
al., 1998), suggests that ATP may not be released extrasynaptically in the adult 
nervous system, or perhaps it may be released with different kinetics than what 
we have observed in vitro.  Indeed, extrasynaptic release of ATP has been 
reported from large diameter sensory afferents in the spinal cord (Sawynok et 
al., 1993; Sawynok and Liu, 2003).  Various technical issues related to in situ 
calcium imaging (i.e. difficulties in loading calcium indicators into myelinated 
segments of nerves) may also contribute to the lack of calcium responses in 
myelinating SCs proximal to the nerve terminal.  Future experiments 
investigating purinergic receptor expression, as well as ATP release in adult vs. 
embryonic myelinated and non-myelinated nerves, may help resolve these 
discrepancies, as well as provide important insight into possible developmental 
regulation of purinergic signaling between axons and SCs in vivo. 
 
CORRELATIONS BETWEEN ACTIVITY PATTERNS AND KEY SC 
DEVELOPMENTAL STAGES IN EMBRYONIC PERIPHERAL NERVES 
IN VIVO AND IN VITRO 
 Comparisons of the electrophysiological properties of embryonic 
sensory neurons  in vivo  with Schwann cell lineage studies in the developing 
rodent sciatic nerve, reveal striking parallels between the timecourse and firing 







development before the onset of myelination (Fitzgerald, 1987; Jessen and 
Mirsky, 1991, 2002) (see fig 27).   
 In the rat, axons project out into the hind limb between E13 and E14.  
At this stage, SC precursor cells are associated with axons that are vigorously 
growing toward their target tissue.  Recordings from single embryonic lumbar 
DRG neurons reveal significant spontaneous activity (0.5 Hz- 2 Hz) beginning 
at ~E16, and peaking at E 18-19.  The onset of spontaneous activity 
corresponds with the transition of SC precursors to embryonic, premyelinating 
SCs.  This is the stage at which SCs first express the S100 antigen, initiate 
autocrine survival loops, and begin proliferation in response to β neuregulin 
and axon-derived mitogens.  The onset of low frequency stimulus-evoked 
firing (10-20 Hz) occurs ~ E17, which corresponds precisely to the first 
appearance of the 04 antigen on the surface of pre-myelinating SCs in vivo. 
This is also the stage at which DRG afferents innervate central targets in spinal 
cord grey matter.  The frequency of firing and the total number of impulses 
increase steadily between E17 and birth, when pre-myelinating SC envelope 
bundles of axons, form a basal lamina, and begin differentiation in to 
myelinating or non-myelinating phenotyes.  Spontaneous activity completely 
 disappears by birth, and is absent in the postnatal period, when myelination 
begins.   
 While it is not yet known whether ATP is released from developing 







course and pattern of impulse activity with key stages in SC development 
suggest that activity-dependent release could have significant effects on SC 
development in vivo.  The present research demonstrated that ATP is released 
from DRG axons following electrical stimulation at frequencies comparable to 
the firing patterns observed in rat DRG neurons in vivo during the 
premyelination period (10 Hz).  In addition, calcium imaging experiments 
indicate that SCs respond to axonal activity in a frequency-dependent manner 
(1 and 3 Hz vs. 10 Hz) (Chapter 2, Fig 4C).  We also have preliminary 
evidence suggesting that ATP is released from DRG axons in response to 
different patterns of impulse activity.   
   Our DRG/SC co-culture model closely models the time course of SC 
developmental stages described in vivo.  Robust proliferation of S100-positive 
SC occurs during the first several days in co-culture, which correspond to the 
pre-myelinating stage.  Expression of the 04 marker is observed after ~1 week, 
and increases slowly with days in co-culture.  Addition of ascorbic acid 
induces basal lamina formation, and strongly up regulates the expression of 04, 
and other differentiation markers. The first MBP-positive myelin profile is 
generally observed about a week after addition of ascorbic acid (Stevens et al., 
1998). 
 Since the onset of neural impulse activity corresponds to the pre-
myelinating period of SC development, we hypothesized that ATP release 







differentiation, and possibly myelination (Experimental Aim 2).  Indeed, SC 
differentiation and proliferation were inhibited by action potential activity in 
our DRG/SC co-culture model.   Chronic electrical stimulation of post-mitotic 
DRG/SC co-cultures significantly inhibited the expression of 04 in pre-
myelinating SCs.  This period in culture may correspond to the onset of 
stimulus-evoked firing (10-20 Hz) at embryonic day 17.  In addition, high 
frequency stimulation of DRG/SC co-cultures significantly inhibited axon-
induced SC proliferation, which was blocked by apyrase, implicating 
extracellular ATP.  These findings correlate with the dramatic inhibition of 
proliferation that occurs in vivo before the onset of myelination, when DRG 
axons are firing at higher frequencies.  The specific mechanisms mediating 
activity-dependent regulation of Schwann cell function will be further 
discussed in the next passage. 
  
ACTIVITY-DEPENDENT RELEASE OF PURINERGIC SIGALING 
MOLECULES REGULATES SCHWANN CELL FUNTION DURING 
DEVELOPMENT  
 We previously reported that chronic, low frequency electrical 
stimulation of DRG/SC co-cultures inhibits PNS myelination (Stevens et al., 
1998).  This inhibition only occurred following electrical stimulation at the 
firing pattern and duration (0.1 Hz, 5 days) that specifically down-regulated the 







interactions between L1 expressed on axons and SCs is important for the initial 
stages of ensheathment that precedes myelination (Seilheimer and Schachner, 
1988; Wood et al., 1990b). We concluded that electrical activity disrupted L1-
mediated axon-SC interactions, and inhibited SC myelination via regulating 
molecules expressed on the axon (Stevens et al., 1998).   
 The present research provides evidence for a second mechanism by 
which neural impulse activity inhibits SC myelination.  This study was the first 
to demonstrate a direct effect of action potential activity on Schwann cell 
development through the release of a soluble signaling molecule from axons.  
As described in chapter 3, extracellular ATP had profound effects on Schwann 
cell development. Activity-dependent release of ATP significantly inhibited 
SC proliferation, and arrested SC differentiation at an immature, pre-
myelinating stage prior to onset of 04 expression.  Chronic treatment of 
SC/DRG co-cultures with ATP maintained SCs in a morphologically immature 
stage, and completely prevented the formation of myelin (Stevens and Fields, 
2000).   
 Importantly, chronic stimulation mimicked the effects of ATP in 
inhibiting SC differentiation and 04 expression, suggesting that ATP can arrest 
differentiation under physiological conditions.   It is important to note that the 
experimental design and stimulation conditions were dramatically different 
from the conditions that inhibited L1-mediated myelination described above 







after DRG/SC co-cultures were established.  Thus, at the time of stimulation, 
most SCs were associated with axons, and were post-mitotic. Co-cultures were 
subsequently stimulated for up to one week in the absence of ascorbic acid, at a 
high frequency, phasic pattern (5 pulses at 10 Hz at 2 sec intervals).  We have 
established that this pattern of firing significantly increases ATP release  
(Chapter 2, Fig 6A) (Stevens and Fields, 2000).   
  In contrast, in the L1 myelin study, low frequency electrical 
stimulation (0.1 Hz for 5 days) was initiated 1 day after SCs were co-cultured 
with neurons (Stevens et al., 1998).  In this paradigm, electrical stimulation 
was carried out during the initial stages of SC adhesion, and association with 
axons when homophilic L1-L1 interactions play a critical role.  In these 
experiments, co-cultures were switched into differentiating medium five days 
after co-culture, and myelination was significantly reduced 10 days later 
following 0.1 Hz, but not  higher frequency conditions (1 and 3 Hz).  We have 
preliminary data indicating ATP release is frequency-dependent, and calcium 
imaging experiments indicate that fewer SCs responded, albeit robustly, with 
increased latency following electrical stimulation at lower frequencies (1 and 3 
Hz vs. 10 Hz) (Chapter 2, Fig 4C).  Thus, it is possible that ATP may not 
affect the initial stages of SC-axon association, suggesting the timing of ATP 








PURINERGIC SIGNALING IN PRE-MYELIMNATING SCHWANN 
CELLS 
 The unexpected finding that pre-myelinating SCs express adenosine 
receptors, suggested that the functional effects described thus far could be 
mediated by ATP, adenosine, or both. While this discovery complicates the 
story considerably, it highlights the complexity of purinergic signaling, and 
suggests that ATP, and its metabolites (ADP, AMP, adenosine), could 
modulate Schwann cell gene expression and function through multiple 
mechanisms.  Indeed, this has been demonstrated in many cell types, including 
astrocytes.  Different families of purinergic receptors (i.e. ATP [P2] vs. 
Adenosine [P1]) can activate different second messengers and consequently 
distinct intracellular signaling pathways.  This is also the case for different 
subtypes of purinergic receptors within the same family (i.e.  P2Y1 vs. P2Y2).  
For example, distinct P2Y subtypes can recruit different MEK activators in 
cultured astrocytes (Lenz et al., 2000; Lenz et al., 2001).   
 Since extracellular ATP can activate multiple types of purinergic 
receptors (see chapter 1, Fig 3), we explored the specific purinergic receptors 
and signaling pathways that could regulate ATP-mediated functional effects in 
SCs (Experimental Aim 3).  Chapter 4 presented pharmacological, molecular, 
and functional evidence that pre-myelinating SCs express a far more complex 
array of ATP (P2X and P2Y) receptors than previously thought.   Surprisingly, 







receptors (A2a and A2b).  These findings are the first to demonstrate 
functional adenosine receptors in SCs, with the exception of specialized 
terminal SCs at the neuromuscular junction, which express calcium-dependent 
A1 adenosine receptors (Robitaille, 1995).  These recent findings lead us to re-
examine some of our previous experiments involving chronic treatment of SCs 
with extracellular ATP.  Since ATP is rapidly degraded to adenosine by 
ectonucleotidases, adenosine may have contributed to the ATP-mediated 
inhibition of SC proliferation and /or differentiation. 
 
REGULATION OF SC PROLIFERATION AND DIFFERENTIATION BY 
ATP AND ADENOSINE 
 Using more selective adenosine and ATP receptors agonists, it was 
determined that both ATP and adenosine inhibited SC proliferation. Chronic 
treatment with adenosine, the general agonist NECA, as well as the A2a 
receptor agonist, CGS21680, significantly inhibited growth factor-stimulated 
SC proliferation compared to controls (Chapter 5).  In addition, P2Y receptor 
agonists also significantly inhibited SC proliferation, while general P2X 
agonists were without significant effect.  That 2MeSATP and 2MeSADP both 
inhibited SC proliferation, suggested that the ATP-mediated responses were 
likely mediated by P2Y1 receptors.  While the specific pathways mediating the 







determined, these findings provided important insights as to how these 
receptors differentially regulated MAPK signaling in premyelinating SCs. 
 It is widely appreciated that ERK/MAPK represents a point of 
convergence from multiple intracellular signaling cascades coupled to diverse 
membrane receptors. ERK/MAPK appears to integrate and communicate this 
information to the nucleus to regulate genes involved in cell cycle and 
differentiation (Bhalla and Iyengar, 2001; Bhalla et al., 2002).  In Schwann 
cells, the ERK/MAPK cascade represents a point of cross-talk between growth 
factors and cAMP signaling pathways, whereby cAMP can either enhance or 
inhibit growth-factor mediated ERK signaling, and proliferation.  For example, 
cAMP can synergize with growth factors to activate ERK/MAPK and 
stimulate cell cycle progression (Kim et al., 1997a; Kim et al., 2001a; Stevens 
and Fields, 2002), or it can significantly reduce  growth factor-induced 
ERK/MAPK in SCs (Kim et al., 1997a) and induce SC differentiation.  
Growing evidence suggest that the intracellular concentration of cAMP is 
important in determining the level and duration of ERK/MAPK activity, and 
the ultimate biological outcome in SCs.  For example, low concentration of 
cAMP (0.1mM) can cause high, but transient levels of ERK1/2 in SCs--
conditions that stimulate SCs proliferation.  In contrast, high concentrations of 
cAMP (>1mM), produce smaller but prolonged ERK/MAPK--conditions that 







 The identity of the axon signal(s) which increase intracellular cAMP in 
SCs to differentially during development are not known, but our findings 
suggest adenosine as a possible candidate. Adenosine could be released from 
electrically active axons during the time when SCs are exiting from the cell 
cycle, and differentiating into myelinating or nonmyelinating phenotypes. 
Chapter 5 provided evidence that activity-dependent release of adenosine 
activates ERK/MAPK in SCs.  While adenosine was applied with growth 
factors, adenosine inhibited growth-factor stimulation of ERK and SC 
proliferation. Although intracellular cAMP in SCs in response to adenosine or 
A2 receptor agonists were not directly determined in this study, G-protein 
coupled -A2 adenosine receptors are positively coupled to adenosine and 
increase intracellular cAMP.  In addition, cAMP-dependent activation of 
ERK1/2 by Gs-coupled A2a and b receptors have been shown in several cell 
types (Schulte and Fredholm, 2003).  Together these data suggest that 
adenosine interacts with growth factors to modulate ERK/MAPK in SCs. This 
may be a mechanism by which adenosine could either over-ride or synergize 
with mitogenic signals to regulate SC proliferation. These findings are in line 
with the longstanding observations that cAMP can have opposing effects on 
ERK and SC function in differentiated vs. pre-differentiated stage in 
development.   
 Activation of P2Y/ATP receptors also inhibited SC proliferation.  In 







suggest that ATP-dependent inhibition of ERK is dependent on P2Y1-receptor 
activation of p38 MAPK in SCs.  Negative regulation of ERK by p38MAPK 
has been recently demonstrated in several reports, and the p38 MAPK pathway 
has been shown to inhibit proliferation and induce cell cycle arrest in a many 
cell types.  Although the mechanisms by which p38 negatively regulates 
ERK1/2 in SCs remains to be determined,  it is tempting to speculate that 
ATP-dependent inhibition of ERK by p38 MAPK could underlie ATP/P2Y 
receptor mediated inhibition of SC proliferation. This hypothesis is in line with 
our findings that ATP receptor activation in SCs inhibited cyclin D1, positively 
regulated p21, and induced G1 arrest in the presence of growth factors 
(Chapter 3).   Purinergic signaling in SCs is exceedingly complex, the present 
research has opened more questions than it has answered. However, our results 
thus far suggest that ATP and adenosine may act together, in cooperation with 
growth factors to modulate MAPK signaling in SCs.  Since the levels and 
types of growth factor likely change with development, purinergic signaling 
molecules could have diverse biological outcomes in SCs.  
 Interestingly, in contrast to ATP, chronic treatment of DRG/SC co-
cultures with adenosine (300 µM) does not appear to influence SC 
differentiation (Chapter 4, Fig. 14).  Since this experiment was performed 
before A2 adenosine receptors were identified in SCs, it will be important to 
re-evaluate possible roles of adenosine in regulating SC differentiation and 







myelin gene expression.  These signaling studies have highlighted the 
importance of determining a dose response with selective agonists and 
antagonists.  Future studies should include more selective adenosine receptor 
agonists and antagonists at a wide range of concentrations. The identification 
of the specific subtypes of ATP (P2) involved in arresting SC development is 
also currently being investigated.  As described in Chapter 4, 2MeSATP 
mimicked ATP in inhibiting 04 expression, suggesting involvement of P2Y 
receptors. Since 2MeSATP can activate multiple subtypes of P2 receptors, 
including P2X, it will be important to look more closely with selective P2X 
and Y receptor agonists and antagonists.  Identification of the specific P2 
receptor(s) involved, could provide important insights into possible 
downstream signaling pathways involved in regulating PNS myelination. 
 
DIFFERENTIAL EFFECTS OF ATP AND ADENOSINE ON 
DEVELOPMENT OF CENTRAL AND PERIPHERAL GLIA 
 Growing evidence indicate that astrocytes, oligodendrocytes, and 
Schwann cells each express functional ATP and adenosine receptors (Fields 
and Stevens, 2000). Despite this apparent correspondence, recent research has 
demonstrated that the same extracellular signal can result in opposing 
biological outcomes in CNS and PNS glia.  An interesting story is beginning to 
emerge regarding activity-dependent regulation of glial differentiation and 







summarized in Figure 28, ATP appears to be the dominant purinergic signal 
inhibiting SC differentiation and myelination, while adenosine has no apparent 
effect (Stevens and Fields, 2000).  In the CNS, adenosine is the primary 
activity-dependent signal promoting oligodendrocytes differentiation and 
myelination, while ATP has no apparent effect (Stevens et al., 2002b).  
Functional differences also exist between Schwann cells and astrocytes (Neary 
et al., 1998; Franke et al., 2001).  Difference is the number and types of 
purinergic receptors in these cells likely contribute to some of these functional 
differences.  In addition, interactions between purinergic receptors and other 
signaling systems in the extracellular environment may also underlie diverse 











Figure 27.  Correlations between activity patterns in sensory axons and 
key developmental stages in Schwann cells in vivo. (Embryonic day 13 

















 The major goal of this research was to determine whether developing 
Schwann cells respond to neuronal activity. While this goal has been largely 
achieved, the findings have opened more questions than they have answered.  
Purinergic signaling is an important new signaling system between axons and 
Schwann cells, with significant effects on development and myelination.  Yet 
to be determined are a complete characterization of these receptors on SCs, 
how the expression changes during development and in response to injury, and 
how this purinegic signaling system may affect activity -dependent signaling 











Figure 28.  Differential effects of ATP and adenosine on myelinating glia 
in the CNS and PNS.   Results in the PNS represent a summary of the present 
studies (Stevens and Fields, 2000). Results in the CNS are based on the 
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